Transcription	B-protein
factor	I-protein
GATA-3	I-protein
is	O
differentially	O
expressed	O
in	O
murine	B-cell_line
Th1	I-cell_line
and	I-cell_line
Th2	I-cell_line
cells	I-cell_line
and	O
controls	O
Th2-specific	O
expression	O
of	O
the	O
interleukin-5	B-DNA
gene	I-DNA
.	O

Interleukin-5	B-protein
(	O
IL-5	B-protein
)	O
,	O
which	O
is	O
produced	O
by	O
CD4	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
helper	I-cell_type
2	I-cell_type
(	I-cell_type
Th2	I-cell_type
)	I-cell_type
cells	I-cell_type
,	O
but	O
not	O
by	O
Th1	B-cell_type
cells	I-cell_type
,	O
plays	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
eosinophilia	O
in	O
asthma	O
.	O

Despite	O
increasing	O
evidence	O
that	O
the	O
outcome	O
of	O
many	O
diseases	O
is	O
determined	O
by	O
the	O
ratio	O
of	O
the	O
two	O
subsets	O
of	O
CD4	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
helper	I-cell_type
cells	I-cell_type
,	O
Th1	B-cell_type
and	O
Th2	B-cell_type
,	O
the	O
molecular	O
basis	O
for	O
Th1-	O
and	O
Th2-	O
specific	O
gene	O
expression	O
remains	O
to	O
be	O
elucidated	O
.	O

We	O
previously	O
established	O
a	O
critical	O
role	O
for	O
the	O
transcription	B-protein
factor	I-protein
GATA-3	B-protein
in	O
IL-5	B-DNA
promoter	I-DNA
activation	O
in	O
EL-4	B-cell_line
cells	I-cell_line
,	O
which	O
express	O
both	O
Th1-	B-protein
and	I-protein
Th2-type	I-protein
cytokines	I-protein
.	O

Our	O
studies	O
reported	O
here	O
demonstrate	O
that	O
GATA-3	B-protein
is	O
critical	O
for	O
expression	O
of	O
the	O
IL-5	B-protein
gene	O
in	O
bona	B-cell_type
fide	I-cell_type
Th2	I-cell_type
cells	I-cell_type
.	O

Whereas	O
mutations	O
in	O
the	O
GATA-3	B-protein
site	O
abolished	O
antigen-	O
or	O
cAMP-	O
stimulated	O
IL-5	O
promoter	O
activation	O
in	O
Th2	O
cells	O
,	O
ectopic	O
expression	O
of	O
GATA-3	B-protein
in	O
Th1	B-cell_type
cells	I-cell_type
or	O
in	O
a	O
non-lymphoid	B-cell_line
,	I-cell_line
non-IL-5-producing	I-cell_line
cell	I-cell_line
line	I-cell_line
activated	O
the	O
IL-5	B-DNA
promoter	I-DNA
.	O

During	O
the	O
differentiation	O
of	O
naive	B-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
isolated	O
from	O
T	O
cell	O
receptor	O
transgenic	O
mice	O
,	O
GATA-3	B-protein
gene	O
expression	O
was	O
up-regulated	O
in	O
developing	O
Th2	B-cell_type
cells	I-cell_type
,	O
but	O
was	O
down-regulated	O
in	O
Th1	B-cell_type
cells	I-cell_type
,	O
and	O
antigen-	B-cell_type
or	I-cell_type
cAMP-activated	I-cell_type
Th2	I-cell_type
cells	I-cell_type
(	O
but	O
not	O
Th1	B-cell_type
cells	I-cell_type
)	O
expressed	O
the	O
GATA-3	B-protein
protein	I-protein
.	O

Thus	O
,	O
GATA-3	B-protein
may	O
play	O
an	O
important	O
role	O
in	O
the	O
balance	O
between	O
Th1	B-cell_type
and	O
Th2	B-cell_type
subsets	I-cell_type
in	O
immune	O
responses	O
.	O

Inhibition	O
of	O
GATA-3	B-protein
activity	O
has	O
therapeutic	O
potential	O
in	O
the	O
treatment	O
of	O
asthma	O
and	O
other	O
hypereosinophilic	O
diseases	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

34	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
22	NULL
,	NULL
pp	NULL
.	NULL

21597-21603	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Transcription	NULL
Factor	NULL
GATA-3	NULL
Is	NULL
Differentially	NULL
Expressed	NULL
in	NULL
Murine	NULL
Thl1	NULL
and	NULL
Th2	NULL
Cells	NULL
and	NULL
Controls	NULL
Th2-specific	NULL
Expression	NULL
of	NULL
the	NULL
Interleukin-5	NULL
Gene*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
2	NULL
,	NULL
1997	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
5	NULL
,	NULL
1997	NULL
)	NULL
Dong-Hong	NULL
Zhang	NULL
}	NULL
,	NULL
Lauren	NULL
Cohn	NULL
#	NULL
§	NULL
,	NULL
Prabir	NULL
Rayt	NULL
#	NULL
,	NULL
Kim	NULL
Bottomly§1	NULL
,	NULL
and	NULL
Anuradha	NULL
Rayt|	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Section	NULL
,	NULL
the	NULL
§Section	NULL
of	NULL
Immunobiology	NULL
,	NULL
and	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06520	NULL
Interleukin-5	NULL
(	NULL
IL-5	NULL
)	NULL
,	NULL
which	NULL
is	NULL
produced	NULL
by	NULL
CD4*	NULL
T	NULL
helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
by	NULL
Th1	NULL
cells	NULL
,	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
eosinophilia	NULL
in	NULL
asthma	NULL
.	NULL

Despite	NULL
increasing	NULL
evidence	NULL
that	NULL
the	NULL
outcome	NULL
of	NULL
many	NULL
diseases	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
two	NULL
subsets	NULL
of	NULL
CD4*	NULL
T	NULL
helper	NULL
cells	NULL
,	NULL
Th1	NULL
and	NULL
Th2	NULL
,	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
gene	NULL
expression	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

We	NULL
previously	NULL
established	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
in	NULL
IL-5	NULL
promoter	NULL
activation	NULL
in	NULL
EL-4	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
both	NULL
Thl-	NULL
and	NULL
Th2-type	NULL
cytokines	NULL
.	NULL

Our	NULL
studies	NULL
reported	NULL
here	NULL
demonstrate	NULL
that	NULL
GATA-3	NULL
is	NULL
critical	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
in	NULL
bona	NULL
fide	NULL
Th2	NULL
cells	NULL
.	NULL

Whereas	NULL
mutations	NULL
in	NULL
the	NULL
GATA-3	NULL
site	NULL
abolished	NULL
antigen-or	NULL
cAMP	NULL
-stimulated	NULL
IL-5	NULL
promoter	NULL
activation	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
ectopic	NULL
expression	NULL
of	NULL
GATA-3	NULL
in	NULL
Thl	NULL
cells	NULL
or	NULL
in	NULL
a	NULL
non-lymphoid	NULL
,	NULL
non-IL-5-producing	NULL
cell	NULL
line	NULL
activated	NULL
the	NULL
IL-5	NULL
promoter	NULL
.	NULL

During	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
T	NULL
cell	NULL
receptor	NULL
transgenic	NULL
mice	NULL
,	NULL
GATA-3	NULL
gene	NULL
expression	NULL
was	NULL
up-regulated	NULL
in	NULL
developing	NULL
Th2	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
down-regulated	NULL
in	NULL
Thl	NULL
cells	NULL
,	NULL
and	NULL
antigen-	NULL
or	NULL
cAMP	NULL
-activated	NULL
Th2	NULL
cells	NULL
(	NULL
but	NULL
not	NULL
Thl	NULL
cells	NULL
)	NULL
expressed	NULL
the	NULL
GATA-3	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
GATA-3	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
balance	NULL
between	NULL
Thl	NULL
and	NULL
Th2	NULL
subsets	NULL
in	NULL
immune	NULL
responses	NULL
.	NULL

Inhibition	NULL
of	NULL
GATA-3	NULL
activity	NULL
has	NULL
therapeutic	NULL
potential	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
asthma	NULL
and	NULL
other	NULL
hypereosinophilic	NULL
diseases	NULL
.	NULL

Activated	NULL
CD4*	NULL
T	NULL
cells	NULL
are	NULL
subdivided	NULL
into	NULL
two	NULL
subsets	NULL
,	NULL
T	NULL
helper	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
Th2	NULL
,	NULL
based	NULL
on	NULL
their	NULL
biological	NULL
functions	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
depend	NULL
on	NULL
the	NULL
cytokines	NULL
they	NULL
produce	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Th1	NULL
cells	NULL
produce	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
``	NULL
and	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
and	NULL
stimulate	NULL
microbicidal	NULL
activity	NULL
in	NULL
macrophages	NULL
and	NULL
promote	NULL
cell-mediated	NULL
immunity	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

Th2	NULL
cells	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
produce	NULL
IL-4	NULL
and	NULL
IL-5	NULL
,	NULL
which	NULL
stimulate	NULL
IgF	NULL
production	NULL
and	NULL
eosinophilic	NULL
inflammation	NULL
,	NULL
respectively	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

There	NULL
is	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
AI81187	NULL
and	NULL
Specialized	NULL
Center	NULL
for	NULL
Research	NULL
in	NULL
Asthma	NULL
Grant	NULL
P50	NULL
HL56389	NULL
(	NULL
to	NULL
A.	NULL
R.	NULL
)	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
HL52014	NULL
(	NULL
to	NULL
P.	NULL
R.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Section	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
P.	NULL
O	NULL
.	NULL

Box	NULL
208057	NULL
,	NULL
383	NULL
Cedar	NULL
St.	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06520	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
208-787-2705	NULL
;	NULL
Fax	NULL
:	NULL
208-785-8826	NULL
;	NULL
E-mail	NULL
:	NULL
Anuradha.Ray	NULL
@	NULL
qm.yale.edu	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
IFN-y	NULL
,	NULL
interferon-y	NULL
;	NULL
Bt	NULL
,	NULL
cAMP	NULL
,	NULL
dibutyryl	NULL
cyclic	NULL
AMP	NULL
;	NULL
EMSAs	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
;	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
APCs	NULL
,	NULL
antigen-presenting	NULL
cells	NULL
;	NULL
Ag	NULL
,	NULL
antigen	NULL
;	NULL
ELISA	NULL
,	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
Ab	NULL
,	NULL
antibody	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-18-acetate	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
good	NULL
evidence	NULL
that	NULL
in	NULL
atopic	NULL
asthmatics	NULL
,	NULL
a	NULL
Th2-type	NULL
response	NULL
occurs	NULL
in	NULL
the	NULL
airways	NULL
(	NULL
5-8	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
outcome	NULL
of	NULL
many	NULL
diseases	NULL
such	NULL
as	NULL
asthma	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
Th1l	NULL
to	NULL
Th2	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
gene	NULL
expression	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Asthma	NULL
is	NULL
a	NULL
chronic	NULL
obstructive	NULL
disease	NULL
of	NULL
the	NULL
small	NULL
airways	NULL
.	NULL

Evolving	NULL
evidence	NULL
indicates	NULL
that	NULL
asthma	NULL
is	NULL
the	NULL
result	NULL
of	NULL
an	NULL
inflammatory	NULL
process	NULL
interacting	NULL
with	NULL
a	NULL
susceptible	NULL
airway	NULL
best	NULL
defined	NULL
at	NULL
present	NULL
as	NULL
airway	NULL
hyperresponsiveness	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
asthma	NULL
,	NULL
the	NULL
most	NULL
striking	NULL
and	NULL
consistent	NULL
pathophysiology	NULL
is	NULL
damage	NULL
to	NULL
the	NULL
bronchial	NULL
epithelium	NULL
caused	NULL
by	NULL
cytotoxic	NULL
cati-onic	NULL
proteins	NULL
released	NULL
by	NULL
infiltrating	NULL
eosinophils	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Various	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
secreted	NULL
products	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
the	NULL
cytokine	NULL
IL-5	NULL
,	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
orchestrating	NULL
the	NULL
unique	NULL
inflammatory	NULL
response	NULL
seen	NULL
in	NULL
asthma	NULL
.	NULL

Since	NULL
it	NULL
was	NULL
isolated	NULL
and	NULL
cloned	NULL
in	NULL
the	NULL
mid-1980s	NULL
,	NULL
the	NULL
intimate	NULL
relationship	NULL
between	NULL
IL-5	NULL
,	NULL
eosinophils	NULL
,	NULL
and	NULL
asthma	NULL
has	NULL
been	NULL
extensively	NULL
documented	NULL
(	NULL
12	NULL
)	NULL
.	NULL

IL-5	NULL
has	NULL
multiple	NULL
effects	NULL
on	NULL
the	NULL
biology	NULL
of	NULL
eosinophils	NULL
not	NULL
limited	NULL
to	NULL
differentiation	NULL
,	NULL
proliferation	NULL
,	NULL
recruitment	NULL
,	NULL
and	NULL
activation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Increasing	NULL
evidence	NULL
places	NULL
IL-5	NULL
in	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
eosinophilia	NULL
in	NULL
asthma	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

IL-5	NULL
mRNA	NULL
was	NULL
significantly	NULL
enhanced	NULL
in	NULL
bronchoalveolar	NULL
lavage	NULL
cells	NULL
obtained	NULL
from	NULL
asthmatics	NULL
challenged	NULL
with	NULL
ragweed	NULL
antigen	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
from	NULL
asthmatics	NULL
were	NULL
found	NULL
to	NULL
secrete	NULL
IL-5	NULL
in	NULL
response	NULL
to	NULL
the	NULL
common	NULL
house	NULL
dust	NULL
mite	NULL
(	NULL
Dermatopha-goides	NULL
farinae	NULL
)	NULL
antigen	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Most	NULL
striking	NULL
,	NULL
in	NULL
ovalbumin-sen-sitized	NULL
guinea	NULL
pigs	NULL
and	NULL
mice	NULL
,	NULL
monoclonal	NULL
antibody	NULL
to	NULL
IL-5	NULL
decreased	NULL
pulmonary	NULL
eosinophilia	NULL
and	NULL
prevented	NULL
the	NULL
development	NULL
of	NULL
airway	NULL
hyperresponsiveness	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
a	NULL
mouse	NULL
model	NULL
of	NULL
asthma	NULL
,	NULL
IL-5-deficient	NULL
mice	NULL
were	NULL
found	NULL
to	NULL
lack	NULL
eosinophilia	NULL
,	NULL
lung	NULL
pathology	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
,	NULL
and	NULL
airway	NULL
hyperresponsiveness	NULL
upon	NULL
allergen	NULL
challenge	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
both	NULL
humans	NULL
and	NULL
mice	NULL
,	NULL
the	NULL
production	NULL
of	NULL
IL-5	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
few	NULL
cell	NULL
types	NULL
,	NULL
which	NULL
include	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
,	NULL
mast	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
eosinophils	NULL
(	NULL
19	NULL
)	NULL
,	NULL
the	NULL
predominant	NULL
source	NULL
being	NULL
T	NULL
cells	NULL
of	NULL
the	NULL
Th2-type	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
general	NULL
,	NULL
IL-5	NULL
is	NULL
not	NULL
produced	NULL
constitutively	NULL
by	NULL
Th2	NULL
cells	NULL
.	NULL

IL-5	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
stimulated	NULL
by	NULL
antigen	NULL
,	NULL
mitogens	NULL
(	NULL
concanavalin	NULL
A	NULL
)	NULL
,	NULL
eicosanoid	NULL
compounds	NULL
(	NULL
leukotriene	NULL
B	NULL
,	NULL
and	NULL
prostaglandins	NULL
)	NULL
,	NULL
and	NULL
cytokines	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Intracellular	NULL
cAMP	NULL
-increasing	NULL
agents	NULL
,	NULL
such	NULL
as	NULL
IL-1	NULL
@	NULL
,	NULL
pros-taglandin	NULL
E	NULL
;	NULL
,	NULL
and	NULL
the	NULL
cAMP	NULL
analogue	NULL
dibutyryl	NULL
cyclic	NULL
AMP	NULL
(	NULL
Bt	NULL
;	NULL
cAMP	NULL
)	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
differentially	NULL
regulate	NULL
cytokine	NULL
production	NULL
by	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Whereas	NULL
the	NULL
production	NULL
of	NULL
the	NULL
Thl	NULL
response-inducing	NULL
cytokine	NULL
IL-12	NULL
and	NULL
that	NULL
of	NULL
the	NULL
Thl	NULL
cytokines	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
are	NULL
inhibited	NULL
by	NULL
cAMP-increasing	NULL
agents	NULL
,	NULL
the	NULL
production	NULL
of	NULL
IL-5	NULL
is	NULL
strongly	NULL
induced	NULL
by	NULL
the	NULL
same	NULL
agents	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
immunoregulatory	NULL
role	NULL
for	NULL
this	NULL
second	NULL
messenger	NULL
(	NULL
21-24	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
Th2	NULL
cell-specific	NULL
IL-5	NULL
gene	NULL
expression	NULL
are	NULL
unclear	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
studies	NULL
of	NULL
IL-5	NULL
21597	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
21598	NULL
promoter	NULL
activation	NULL
by	NULL
cAMP	NULL
in	NULL
the	NULL
murine	NULL
cell	NULL
line	NULL
EL-4	NULL
,	NULL
which	NULL
expresses	NULL
both	NULL
Th2-	NULL
and	NULL
Th1-type	NULL
cytokines	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
to	NULL
-66	NULL
,	NULL
which	NULL
disrupted	NULL
a	NULL
GATA	NULL
site	NULL
located	NULL
between	NULL
-70	NULL
and	NULL
-60	NULL
,	NULL
abolished	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
,	NULL
but	NULL
not	NULL
GATA-4	NULL
,	NULL
binds	NULL
to	NULL
this	NULL
GATA	NULL
site	NULL
(	NULL
25	NULL
)	NULL
.	NULL

This	NULL
was	NULL
the	NULL
first	NULL
description	NULL
of	NULL
the	NULL
involvement	NULL
of	NULL
GATA-3	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
any	NULL
cytokine	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Yamagata	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
,	NULL
in	NULL
their	NULL
studies	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
IL-5	NULL
gene	NULL
in	NULL
the	NULL
ATL-16T	NULL
cell	NULL
line	NULL
,	NULL
also	NULL
demonstrated	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
IL-5	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
two	NULL
important	NULL
points	NULL
merit	NULL
consideration	NULL
in	NULL
comparing	NULL
these	NULL
two	NULL
studies	NULL
.	NULL

First	NULL
,	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
ATL-16T	NULL
cells	NULL
is	NULL
largely	NULL
constitutive	NULL
(	NULL
27	NULL
)	NULL
.	NULL
``	NULL

However	NULL
,	NULL
in	NULL
both	NULL
humans	NULL
and	NULL
mice	NULL
,	NULL
the	NULL
IL-5	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
an	NULL
inducible	NULL
fashion	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
the	NULL
ATL-16T	NULL
cells	NULL
do	NULL
not	NULL
reflect	NULL
the	NULL
typical	NULL
expression	NULL
characteristics	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
either	NULL
in	NULL
humans	NULL
or	NULL
in	NULL
mice	NULL
.	NULL

Second	NULL
,	NULL
GATA-4	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
the	NULL
heart	NULL
,	NULL
intestines	NULL
,	NULL
epithelium	NULL
,	NULL
and	NULL
reproductive	NULL
organs	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
low	NULL
or	NULL
undetectable	NULL
in	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
T	NULL
cells	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
atypical	NULL
high	NULL
level	NULL
of	NULL
GATA-4	NULL
activity	NULL
in	NULL
ATL-16T	NULL
cells	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
atypical	NULL
(	NULL
constitutive	NULL
)	NULL
nature	NULL
of	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
another	NULL
study	NULL
,	NULL
Prieschl	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
GATA	NULL
site	NULL
located	NULL
between	NULL
-70	NULL
and	NULL
-60	NULL
in	NULL
the	NULL
IL-5	NULL
promoter	NULL
is	NULL
also	NULL
important	NULL
for	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
mast	NULL
cells	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
additionally	NULL
demonstrated	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
also	NULL
requires	NULL
an	NULL
intact	NULL
AP-1	NULL
site	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
consensus	NULL
lym-phokine	NULL
element	NULL
0	NULL
)	NULL
located	NULL
between	NULL
-53	NULL
and	NULL
-39	NULL
in	NULL
the	NULL
pro-moter	NULL
;	NULL
mutation	NULL
of	NULL
this	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
an	NULL
~550-bp	NULL
promoter	NULL
totally	NULL
abrogated	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
crucial	NULL
for	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
bona	NULL
fide	NULL
Th2	NULL
cells	NULL
and	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
GATA-3	NULL
alone	NULL
results	NULL
in	NULL
IL-5	NULL
promoter	NULL
activation	NULL
in	NULL
a	NULL
non-IL-5-producing	NULL
cell	NULL
line	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
GATA-3	NULL
activity	NULL
is	NULL
present	NULL
only	NULL
in	NULL
Th2	NULL
cells	NULL
and	NULL
is	NULL
undetectable	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
GATA-3	NULL
activity	NULL
may	NULL
therefore	NULL
be	NULL
effective	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
asthma	NULL
and	NULL
other	NULL
hypereosinophilic	NULL
diseases	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Generation	NULL
and	NULL
Maintenance	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
Cells-Both	NULL
DIO	NULL
and	NULL
C19	NULL
clones	NULL
were	NULL
maintained	NULL
in	NULL
Click	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
5	NULL
units/ml	NULL
murine	NULL
recombinant	NULL
IL-2	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
50	NULL
uM	NULL
B-mercaptoethanol	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
gentamycin	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
(	NULL
81	NULL
,	NULL
82	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
every	NULL
2	NULL
weeks	NULL
with	NULL
the	NULL
specific	NULL
antigen	NULL
(	NULL
conalbumin	NULL
for	NULL
D10	NULL
cells	NULL
,	NULL
used	NULL
at	NULL
100	NULL
ug/ml	NULL
)	NULL
and	NULL
peptide	NULL
AC1-16	NULL
(	NULL
ASQKRPSQRHGSKYL	NULL
;	NULL
derived	NULL
from	NULL
myelin	NULL
basic	NULL
protein	NULL
,	NULL
used	NULL
at	NULL
5	NULL
ug/ml	NULL
)	NULL
and	NULL
mitomycin	NULL
C-treated	NULL
splenocytes	NULL
from	NULL
syngeneic	NULL
mice	NULL
(	NULL
I-A*	NULL
for	NULL
D10	NULL
cells	NULL
and	NULL
I-A	NULL
``	NULL
for	NULL
C19	NULL
cells	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
use	NULL
in	NULL
experiments	NULL
,	NULL
dead	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
density	NULL
gradient	NULL
fractionation	NULL
using	NULL
lymphocyte	NULL
separation	NULL
medium	NULL
(	NULL
Organon	NULL
Teknika	NULL
)	NULL
.	NULL

DO11.10	NULL
mice	NULL
,	NULL
which	NULL
are	NULL
transgenic	NULL
for	NULL
the	NULL
TCR	NULL
recognizing	NULL
the	NULL
ovalbumin	NULL
peptide	NULL
828-889	NULL
(	NULL
pOVA®	NULL
``	NULL
``	NULL
~*	NULL
``	NULL
``	NULL
)	NULL
,	NULL
were	NULL
provided	NULL
on	NULL
BALB/c	NULL
background	NULL
by	NULL
Dr.	NULL
Ken	NULL
Murphy	NULL
(	NULL
Washington	NULL
University	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
Th1	NULL
or	NULL
Th2	NULL
cells	NULL
from	NULL
DO11.10	NULL
mice	NULL
,	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
first	NULL
isolated	NULL
from	NULL
the	NULL
spleens	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
CD8	NULL
,	NULL
class	NULL
II	NULL
MHC	NULL
I-A	NULL
``	NULL
,	NULL
and	NULL
anti-Ig-coated	NULL
magnetic	NULL
beads	NULL
(	NULL
Collaborative	NULL
Research	NULL
)	NULL
.	NULL

Cultures	NULL
were	NULL
set	NULL
up	NULL
in	NULL
flasks	NULL
containing	NULL
equal	NULL
numbers	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
.	NULL

To	NULL
generate	NULL
Th1	NULL
cells	NULL
,	NULL
cultures	NULL
contained	NULL
pOVA®*	NULL
``	NULL
``	NULL
~*	NULL
``	NULL
``	NULL
at	NULL
5	NULL
ug/ml	NULL
,	NULL
IL-12	NULL
at	NULL
5	NULL
ng/ml	NULL
,	NULL
IL-2	NULL
at	NULL
10	NULL
units/ml	NULL
,	NULL
and	NULL
anti-IL-4	NULL
at	NULL
inhibitory	NULL
concentrations	NULL
.	NULL

To	NULL
generate	NULL
Th2	NULL
cells	NULL
,	NULL
cultures	NULL
contained	NULL
pOVA*	NULL
``	NULL
*~*	NULL
``	NULL
at	NULL
5	NULL
ug/ml	NULL
,	NULL
IL-4	NULL
at	NULL
200	NULL
units/ml	NULL
,	NULL
IL-2	NULL
at	NULL
10	NULL
units/ml	NULL
,	NULL
and	NULL
anti-IFN-y	NULL
antibody	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
culture	NULL
for	NULL
3	NULL
days	NULL
,	NULL
and	NULL
at	NULL
the	NULL
end	NULL
of	NULL
this	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
further	NULL
stimulated	NULL
with	NULL
fresh	NULL
mitomycin	NULL
C-treated	NULL
and	NULL
'T	NULL
cell-depleted	NULL
APCs	NULL
2	NULL
D.-H.	NULL
Zhang	NULL
and	NULL
A.	NULL
Ray	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

GATA-3	NULL
and	NULL
Th2-specific	NULL
Transcription	NULL
and	NULL
Ag	NULL
for	NULL
8	NULL
or	NULL
24	NULL
h	NULL
(	NULL
for	NULL
making	NULL
nuclear	NULL
extracts	NULL
)	NULL
or	NULL
for	NULL
48	NULL
h	NULL
for	NULL
cytokine	NULL
assays	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
cytokines	NULL
by	NULL
ELISA	NULL
using	NULL
kits	NULL
from	NULL
Endogen	NULL
,	NULL
Inc.	NULL
(	NULL
sensitivity	NULL
:	NULL
IL-4	NULL
,	NULL
6	NULL
pg/ml	NULL
;	NULL
IL-5	NULL
,	NULL
0.1	NULL
ng/ml	NULL
;	NULL
and	NULL
IFN-y	NULL
,	NULL
2	NULL
ng/ml	NULL
)	NULL
.	NULL

RNA	NULL
Isolation	NULL
and	NULL
Northern	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
using	NULL
Trizol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
formaldehyde-agarose	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

DNA	NULL
fragments	NULL
derived	NULL
from	NULL
murine	NULL
GATA-3	NULL
cDNA	NULL
(	NULL
~60-bp	NULL
Bgil-Clal	NULL
fragment	NULL
not	NULL
containing	NULL
any	NULL
part	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
domain	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-*	NULL
``	NULL
PIdCTP	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
using	NULL
QuikHyb	NULL
(	NULL
Stratagene	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Transfection	NULL
Assays-Rested	NULL
D10	NULL
or	NULL
A.E7	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
and	NULL
resuspended	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
DNA	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
cytomegalovirus-B-galactosidase	NULL
plasmid	NULL
as	NULL
a	NULL
monitor	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
and	NULL
carrier	NULL
plasmid	NULL
pGEM7Z	NULL
to	NULL
make	NULL
up	NULL
to	NULL
15	NULL
ug	NULL
of	NULL
total	NULL
DNA	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
electroporation	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
a	NULL
GenePulser	NULL
(	NULL
Bio-Rad	NULL
)	NULL
at	NULL
0.27	NULL
kV	NULL
and	NULL
960	NULL
microfarads	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
10-80	NULL
min	NULL
,	NULL
diluted	NULL
to	NULL
5	NULL
ml	NULL
with	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
or	NULL
without	NULL
Bt	NULL
,	NULL
cAMP	NULL
+	NULL
PMA	NULL
.	NULL

For	NULL
antigen	NULL
stimulation	NULL
,	NULL
rested	NULL
cells	NULL
were	NULL
first	NULL
stimulated	NULL
with	NULL
conalbumin	NULL
and	NULL
mitomycin	NULL
C-treated	NULL
and	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
in	NULL
complete	NULL
medium	NULL
containing	NULL
5	NULL
units/ml	NULL
IL-2	NULL
for	NULL
72	NULL
h	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
electroporation	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
for	NULL
reporter	NULL
gene	NULL
assays	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Hela	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
83	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

All	NULL
APCs	NULL
were	NULL
mitomycin	NULL
C-treated	NULL
and	NULL
depleted	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
in	NULL
the	NULL
EMSAs	NULL
were	NULL
two	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
sequences	NULL
between	NULL
-57	NULL
and	NULL
-34	NULL
(	NULL
containing	NULL
the	NULL
CLEO	NULL
element	NULL
)	NULL
and	NULL
between	NULL
-73	NULL
and	NULL
-54	NULL
(	NULL
containing	NULL
the	NULL
GATA	NULL
element	NULL
)	NULL
in	NULL
the	NULL
IL-5	NULL
gene	NULL
,	NULL
and	NULL
22-bp	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
consensus	NULL
CREB	NULL
element	NULL
(	NULL
from	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
oligonucleotides	NULL
for	NULL
the	NULL
mutant	NULL
CREB	NULL
element	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
EMSAs	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
~°CCTCTATCTGATTGTTAGCA~	NULL
``	NULL
(	NULL
wild-type	NULL
GATA	NULL
)	NULL
,	NULL
CCTCgegaTGATTGTTAGCA	NULL
(	NULL
GATA	NULL
mutant	NULL
1	NULL
)	NULL
,	NULL
CCTC-TATCTGAaaccTAGCA	NULL
(	NULL
GATA	NULL
mutant	NULL
2	NULL
)	NULL
,	NULL
CCTCTATCettTTGTTAGCA	NULL
(	NULL
GATA	NULL
mutant	NULL
8	NULL
)	NULL
,	NULL
and	NULL
~	NULL
``	NULL
AGCAATTATTCATTTCCTCAGAGA-*4	NULL
(	NULL
CLEO	NULL
)	NULL
.	NULL

Complementary	NULL
oligonucleotides	NULL
were	NULL
annealed	NULL
before	NULL
use	NULL
in	NULL
EMSAs	NULL
.	NULL

The	NULL
antibodies	NULL
to	NULL
the	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
GATA-8	NULL
proteins	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

The	NULL
anti-GATA-3	NULL
antibody	NULL
was	NULL
a	NULL
mouse	NULL
monoclonal	NULL
IgG1	NULL
that	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
or	NULL
GATA-4	NULL
.	NULL

The	NULL
anti-Fos	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
Oncogene	NULL
Science	NULL
Inc	NULL
.	NULL

The	NULL
anti-GATA-4	NULL
antibody	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
David	NULL
Wilson	NULL
.	NULL

The	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
acrylamide/bisac-rylamide	NULL
=	NULL
80:1	NULL
)	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
200	NULL
V	NULL
in	NULL
0.5	NULL
X	NULL
TBE	NULL
(	NULL
1	NULL
x	NULL
TBE	NULL
=	NULL
0.05	NULL
M	NULL
Tris	NULL
base	NULL
,	NULL
0.05	NULL
M	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
1.0	NULL
mM	NULL
EDTA	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
We	NULL
have	NULL
used	NULL
the	NULL
established	NULL
nontransformed	NULL
murine	NULL
T	NULL
cell	NULL
clones	NULL
D10.G4.1	NULL
(	NULL
Th2	NULL
)	NULL
(	NULL
31	NULL
)	NULL
and	NULL
C19	NULL
(	NULL
Th1	NULL
)	NULL
(	NULL
32	NULL
)	NULL
and	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
obtained	NULL
by	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
mice	NULL
to	NULL
gain	NULL
insight	NULL
into	NULL
mechanisms	NULL
that	NULL
permit	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
but	NULL
limit	NULL
its	NULL
expression	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

The	NULL
GATA	NULL
Site	NULL
in	NULL
the	NULL
5'-Flanking	NULL
Region	NULL
of	NULL
the	NULL
IL-5	NULL
Gene	NULL
Is	NULL
Critical	NULL
for	NULL
IL-5	NULL
Promoter	NULL
Activation	NULL
in	NULL
Th2	NULL
Cells-In	NULL
our	NULL
previous	NULL
studies	NULL
of	NULL
cAMP-induced	NULL
IL-5	NULL
promoter	NULL
activation	NULL
using	NULL
an	NULL
~550-bp	NULL
promoter	NULL
fragment	NULL
and	NULL
the	NULL
murine	NULL
T	NULL
cell	NULL
line	NULL
EL-4	NULL
,	NULL
we	NULL
had	NULL
identified	NULL
two	NULL
regions	NULL
in	NULL
the	NULL
IL-5	NULL
5'-flanking	NULL
region	NULL
that	NULL
were	NULL
critical	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
:	NULL
one	NULL
was	NULL
the	NULL
AP-1-binding	NULL
site	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
,	NULL
whereas	NULL
the	NULL
other	NULL
was	NULL
a	NULL
region	NULL
between	NULL
-70	NULL
and	NULL
-60	NULL
containing	NULL
two	NULL
overlapping	NULL
GATA	NULL
sites	NULL
,	NULL
deletion	NULL
of	NULL
which	NULL
abrogated	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
by	NULL
Ag	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
we	NULL
transfected	NULL
the	NULL
murine	NULL
Th2	NULL
clone	NULL
D10.G4.1	NULL
(	NULL
31	NULL
)	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
(	NULL
firefly	NULL
luciferase	NULL
)	NULL
construct	NULL
containing	NULL
a	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GATA-3	NULL
and	NULL
Th2-specific	NULL
Transcription	NULL
A	NULL
$	NULL
000	NULL
2500	NULL
+	NULL
[	NULL
J	NULL
unstimulated	NULL
BJ	NULL
PMA+bt	NULL
,	NULL
cAMP	NULL
2000	NULL
4	NULL
1500	NULL
4	NULL
Activity	NULL
4000+	NULL
R	NULL
Ag+APC	NULL
3000	NULL
+	NULL
Luciferase	NULL
2000+	NULL
1000+	NULL
mut	NULL
.	NULL

mut	NULL
.	NULL

mut	NULL
.	NULL

wt	NULL
--	NULL
NPAT	NULL
GATA	NULL
-	NULL
aP1	NULL
__	NULL
PP	NULL
!	NULL

-111	NULL
.	NULL

-107	NULL
wt-NFAT	NULL
:	NULL
5'-GGAAA	NULL
mut	NULL
.	NULL

-NFAT	NULL
:	NULL
5'-ttogA	NULL
-70	NULL
-e0	NULL
--	NULL
-	NULL
>	NULL
wh-GATA	NULL
:	NULL
5'-CTATCTGATTG	NULL
mut	NULL
.	NULL

-GATA	NULL
:	NULL
5'-CTATCettTTG	NULL
-52	NULL
-46	NULL
wt-AP1L	NULL
:	NULL
5'-TTATTCA	NULL
mut	NULL
.	NULL

-AP1	NULL
:	NULL
5'-Tectata	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
murine	NULL
IL-5	NULL
promoter	NULL
in	NULL
D10	NULL
cells	NULL
requires	NULL
the	NULL
GATA-3	NULL
and	NULL
AP-1	NULL
sites	NULL
(	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
)	NULL
,	NULL
but	NULL
not	NULL
the	NULL
NF-AT	NULL
site	NULL
.	NULL

A	NULL
,	NULL
rested	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
by	NULL
electroporation	NULL
and	NULL
either	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
Bt	NULL
,	NULL
cAMP	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
+	NULL
PMA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
(	NULL
w	NULL
?	NULL

¢	NULL
)	NULL
promoter	NULL
contained	NULL
sequences	NULL
between	NULL
approximately	NULL
-1700	NULL
and	NULL
+24	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
individual	NULL
mutations	NULL
were	NULL
made	NULL
in	NULL
the	NULL
context	NULL
of	NULL
this	NULL
fragment	NULL
.	NULL

For	NULL
antigen	NULL
stimulation	NULL
,	NULL
rested	NULL
cells	NULL
were	NULL
first	NULL
stimulated	NULL
with	NULL
conalbumin	NULL
and	NULL
mitomycin	NULL
C-treated	NULL
and	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
in	NULL
complete	NULL
medium	NULL
containing	NULL
5	NULL
units/ml	NULL
IL-2	NULL
for	NULL
72	NULL
h	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
electroporation	NULL
.	NULL

After	NULL
18-20	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
(	NULL
arbitrary	NULL
units	NULL
)	NULL
for	NULL
each	NULL
of	NULL
the	NULL
reporter	NULL
plasmids	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
bar	NULL
graph	NULL
,	NULL
with	NULL
results	NULL
representing	NULL
the	NULL
average	NULL
of	NULL
multiple	NULL
experiments	NULL
and	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
deviations	NULL
were	NULL
no	NULL
more	NULL
than	NULL
15	NULL
%	NULL
between	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
the	NULL
location	NULL
and	NULL
sequence	NULL
of	NULL
the	NULL
three	NULL
site-directed	NULL
mutations	NULL
in	NULL
the	NULL
IL-5	NULL
promoter	NULL
are	NULL
identified	NULL
.	NULL

Base	NULL
pair	NULL
changes	NULL
are	NULL
identified	NULL
with	NULL
lower-case	NULL
letters	NULL
.	NULL

mut	NULL
.	NULL

,	NULL
mutant	NULL
.	NULL

1.7-kb	NULL
promoter	NULL
fragment	NULL
from	NULL
the	NULL
5'-flanking	NULL
region	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
.	NULL

Both	NULL
Ag	NULL
and	NULL
Bt	NULL
,	NULL
cAMP	NULL
+	NULL
PMA	NULL
caused	NULL
a	NULL
10-20-fold	NULL
activation	NULL
of	NULL
the	NULL
wild-type	NULL
IL-5	NULL
promoter	NULL
,	NULL
and	NULL
mutations	NULL
in	NULL
the	NULL
AP-1	NULL
site	NULL
or	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
1.7-kb	NULL
promoter	NULL
completely	NULL
abolished	NULL
activation	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
NF-AT	NULL
site	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-5	NULL
promoter	NULL
activity	NULL
.	NULL

GATA-3	NULL
DNA	NULL
Binding	NULL
Activity	NULL
Is	NULL
Present	NULL
in	NULL
Activated	NULL
Th2	NULL
Cells	NULL
,	NULL
but	NULL
Is	NULL
Absent	NULL
in	NULL
Activated	NULL
Th1	NULL
Cells-We	NULL
next	NULL
investigated	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
GATA	NULL
element	NULL
and	NULL
the	NULL
CLEO	NULL
element	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
Th2	NULL
(	NULL
D10	NULL
)	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
two	NULL
complexes	NULL
were	NULL
detected	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
D10	NULL
cells	NULL
.	NULL

The	NULL
binding	NULL
intensity	NULL
of	NULL
both	NULL
complexes	NULL
was	NULL
augmented	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
Bt	NULL
,	NULL
cAMP	NULL
+	NULL
PMA	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Although	NULL
both	NULL
complexes	NULL
were	NULL
competed	NULL
for	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
,	NULL
competition	NULL
for	NULL
complex	NULL
I	NULL
formation	NULL
was	NULL
incomplete	NULL
even	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unla-	NULL
21599	NULL
beled	NULL
competitor	NULL
,	NULL
suggesting	NULL
that	NULL
complex	NULL
I	NULL
binds	NULL
with	NULL
a	NULL
lower	NULL
affinity	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
than	NULL
complex	NULL
II	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
specific	NULL
mutations	NULL
in	NULL
three	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
double	NULL
GATA	NULL
site	NULL
were	NULL
also	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

Mutant	NULL
1	NULL
contained	NULL
mutations	NULL
in	NULL
the	NULL
distal	NULL
GATA	NULL
sequence	NULL
,	NULL
and	NULL
mutant	NULL
2	NULL
in	NULL
the	NULL
proximal	NULL
sequence	NULL
,	NULL
whereas	NULL
mutant	NULL
3	NULL
was	NULL
mutated	NULL
in	NULL
both	NULL
sequences	NULL
.	NULL

None	NULL
of	NULL
these	NULL
mutants	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
formation	NULL
of	NULL
the	NULL
complexes	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
entire	NULL
sequence	NULL
between	NULL
-70	NULL
and	NULL
-60	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complexes	NULL
(	NULL
Zanes	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
complexes	NULL
(	NULL
especially	NULL
complex	NULL
II	NULL
)	NULL
were	NULL
supershifted	NULL
by	NULL
an	NULL
anti-GATA-3	NULL
antibody	NULL
(	NULL
Ab	NULL
)	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
an	NULL
anti-GATA-4	NULL
antiserum	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
GATA-3	NULL
DNA	NULL
binding	NULL
activity	NULL
between	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
similar	NULL
analysis	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
D10	NULL
and	NULL
C19	NULL
(	NULL
Th1	NULL
)	NULL
cells	NULL
prepared	NULL
in	NULL
the	NULL
same	NULL
experiment	NULL
under	NULL
identical	NULL
conditions	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
D10	NULL
cells	NULL
generated	NULL
two	NULL
complexes	NULL
that	NULL
were	NULL
supershifted	NULL
by	NULL
the	NULL
anti-GATA-3	NULL
Ab	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
anti-GATA-4	NULL
Ab	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

Using	NULL
identical	NULL
protein	NULL
amounts	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
C19	NULL
cells	NULL
,	NULL
we	NULL
detected	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
binding	NULL
activity	NULL
in	NULL
resting	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Upon	NULL
treatment	NULL
of	NULL
the	NULL
C19	NULL
cells	NULL
with	NULL
Bt	NULL
,	NULL
cAMP	NULL
and	NULL
PMA	NULL
,	NULL
whether	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
complexes	NULL
did	NULL
not	NULL
increase	NULL
,	NULL
but	NULL
consistently	NULL
diminished	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
the	NULL
same	NULL
extracts	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
used	NULL
at	NULL
only	NULL
half	NULL
the	NULL
amounts	NULL
used	NULL
in	NULL
the	NULL
GATA-3	NULL
binding	NULL
assays	NULL
,	NULL
robust	NULL
inducible	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
with	NULL
both	NULL
D10	NULL
and	NULL
C19	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
anti-c-Jun	NULL
and	NULL
anti-c-Fos	NULL
(	NULL
reactive	NULL
to	NULL
all	NULL
Fos	NULL
family	NULL
proteins	NULL
)	NULL
Abs	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
with	NULL
either	NULL
extract	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
anti-JunB	NULL
and	NULL
anti-JunD	NULL
Abs	NULL
supershifted/inhib-ited	NULL
complex	NULL
formation	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrated	NULL
that	NULL
D10	NULL
and	NULL
C19	NULL
cells	NULL
contain	NULL
similar	NULL
levels	NULL
of	NULL
AP-1	NULL
binding	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
D10	NULL
cells	NULL
constitutively	NULL
contain	NULL
some	NULL
GATA-3	NULL
DNA	NULL
binding	NULL
activity	NULL
that	NULL
is	NULL
augmented	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
unstimulated	NULL
C19	NULL
cells	NULL
contain	NULL
very	NULL
little	NULL
GATA-3	NULL
DNA	NULL
binding	NULL
activity	NULL
that	NULL
decreases	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Thl1	NULL
and	NULL
Th2	NULL
Cells	NULL
Obtained	NULL
by	NULL
Differentiation	NULL
of	NULL
Naive	NULL
CD4*	NULL
T	NULL
Cells	NULL
Display	NULL
Differential	NULL
GATA-3	NULL
DNA	NULL
Binding	NULL
Ac-tivity-We	NULL
investigated	NULL
whether	NULL
the	NULL
observed	NULL
difference	NULL
in	NULL
GATA-3	NULL
binding	NULL
activity	NULL
between	NULL
the	NULL
Th1	NULL
(	NULL
C19	NULL
)	NULL
and	NULL
Th2	NULL
(	NULL
D10	NULL
)	NULL
clones	NULL
was	NULL
also	NULL
true	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
obtained	NULL
by	NULL
differentiation	NULL
of	NULL
naive	NULL
splenic	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
mice	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
Thl	NULL
and	NULL
Th2	NULL
cells	NULL
stimulated	NULL
with	NULL
Ag	NULL
for	NULL
8	NULL
or	NULL
24	NULL
h	NULL
,	NULL
and	NULL
GATA	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
were	NULL
determined	NULL
with	NULL
the	NULL
extracts	NULL
.	NULL

The	NULL
Th1	NULL
cell	NULL
extract	NULL
from	NULL
both	NULL
time	NULL
points	NULL
generated	NULL
two	NULL
complexes	NULL
with	NULL
the	NULL
GATA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1-6	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
Th2	NULL
extract	NULL
generated	NULL
three	NULL
complexes	NULL
(	NULL
Zanes	NULL
7-12	NULL
)	NULL
.	NULL

Complexes	NULL
I	NULL
and	NULL
II	NULL
were	NULL
of	NULL
the	NULL
same	NULL
mobility	NULL
and	NULL
reactivity	NULL
to	NULL
antisera	NULL
as	NULL
complexes	NULL
I	NULL
and	NULL
II	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Complex	NULL
II	NULL
was	NULL
not	NULL
formed	NULL
with	NULL
the	NULL
Thl	NULL
extract	NULL
.	NULL

A	NULL
new	NULL
complex	NULL
(	NULL
III	NULL
)	NULL
,	NULL
specific	NULL
for	NULL
Ag	NULL
stimulation	NULL
and	NULL
of	NULL
mobility	NULL
intermediate	NULL
between	NULL
complexes	NULL
I	NULL
and	NULL
II	NULL
,	NULL
was	NULL
formed	NULL
with	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
extracts	NULL
.	NULL

Complex	NULL
III	NULL
was	NULL
more	NULL
distinct	NULL
with	NULL
the	NULL
24-h	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
left	NULL
panel	NULL
,	NULL
compare	NULL
lane	NULL
4	NULL
with	NULL
lane	NULL
1	NULL
and	NULL
lane	NULL
10	NULL
with	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Complex	NULL
III	NULL
,	NULL
formed	NULL
with	NULL
both	NULL
the	NULL
Th1	NULL
extracts	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
and	NULL
the	NULL
Th2	NULL
extracts	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
12	NULL
)	NULL
,	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
anti-GATA-4	NULL
antiserum	NULL
.	NULL

However	NULL
,	NULL
the	NULL
anti-GATA-3	NULL
Ab	NULL
did	NULL
not	NULL
react	NULL
with	NULL
any	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
Th1	NULL
extracts	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
in	NULL
our	NULL
EMSAs	NULL
with	NULL
the	NULL
Th2	NULL
extracts	NULL
,	NULL
complex	NULL
I	NULL
was	NULL
slightly	NULL
inhibited	NULL
by	NULL
the	NULL
anti-GATA-3	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
21600	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Th1	NULL
and	NULL
Th2	NULL
clones	NULL
differen-	NULL
A	NULL
Probe	NULL
GATA-3	NULL
and	NULL
Th2-specific	NULL
Transcription	NULL
tially	NULL
express	NULL
GATA-3	NULL
DNA	NULL
binding	NULL
iss	NULL
:	NULL
Bath	NULL
Probe	NULL
,	NULL
_	NULL
IL-5	NULL
_GATA_	NULL
It-6	NULL
LEO	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
shown	NULL
is	NULL
the	NULL
GATA-3	NULL
DNA	NULL
ba	NULL
g	NULL
3	NULL
S	NULL
<	NULL
5	NULL
2	NULL
2	NULL
.	NULL

,	NULL
binding	NULL
activity	NULL
in	NULL
unstimulated	NULL
and	NULL
Antibody	NULL
!	NULL

-o	NULL
a	NULL
e	NULL
G	NULL
E	NULL
6	NULL
Antibody	NULL
|	NULL
_	NULL
_	NULL
§	NULL
§	NULL
{	NULL
o_	NULL
g	NULL
i	NULL
i	NULL
2	NULL
stimulated	NULL
Th2	NULL
(	NULL
D10	NULL
)	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
GATA-3	NULL
competitor	NULL
1	NULL
bof	NULL
:	NULL
§	NULL
f	NULL
$	NULL
PMAbvp	NULL
-	NULL
+	NULL
f	NULL
F	NULL
-	NULL
x	NULL
§	NULL
#	NULL
$	NULL
&	NULL
DNA	NULL
binding	NULL
activity	NULL
increases	NULL
upon	NULL
5.1	NULL
“	NULL
;	NULL
ng	NULL
woy	NULL
Gof	NULL
£	NULL
i	NULL
i	NULL
T	NULL
i	NULL
i	NULL
|	NULL
stimulation	NULL
of	NULL
Th2	NULL
cells	NULL
with	NULL
Bt	NULL
,	NULL
cAMP+	NULL
(	NULL
oe	NULL
e	NULL
~~~	NULL
C19	NULL
b4	NULL
b4	NULL
PMA	NULL
,	NULL
but	NULL
decreases	NULL
in	NULL
similarly	NULL
stimu-	NULL
lated	NULL
Thl	NULL
cells	NULL
,	NULL
whereas	NULL
Thl	NULL
and	NULL
Th2	NULL
13	NULL
>	NULL
u	NULL
«	NULL
<	NULL
-cells	NULL
contain	NULL
equivalent	NULL
CLEO	NULL
binding	NULL
ac-	NULL
I1-	NULL
>	NULL
»	NULL
|	NULL
&	NULL
tivity	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
in	NULL
the	NULL
EMSAs	NULL
were	NULL
two	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
sequences	NULL
between	NULL
(	NULL
i	NULL
)	NULL
-57	NULL
and	NULL
-34	NULL
(	NULL
containing	NULL
the	NULL
CLEO	NULL
element	NULL
)	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
-783	NULL
and	NULL
-54	NULL
(	NULL
containing	NULL
the	NULL
GATA	NULL
element	NULL
)	NULL
in	NULL
the	NULL
IL-5	NULL
gene	NULL
.	NULL

The	NULL
EMSAs	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

2	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
used	NULL
in	NULL
each	NULL
lane	NULL
for	NULL
GATA	NULL
and	NULL
CLEO	NULL
binding	NULL
assays	NULL
,	NULL
respec-tively	NULL
.	NULL

2	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
antibodies	NULL
was	NULL
added	NULL
per	NULL
20-ul	NULL
reaction	NULL
volume	NULL
.	NULL

The	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

mut	NULL
.	NULL

,	NULL
mutant	NULL
.	NULL

|	NULL
-	NULL
%	NULL
»	NULL
WWW	NULL
W	NULL
|	NULL
were	NULL
generated	NULL
by	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
TCR	NULL
trans-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
§	NULL
6	NULL
7	NULL
B	NULL
9	NULL
10	NULL
A	NULL
Probe	NULL
IL-5	NULL
GATA	NULL
IL-5	NULL
cleo	NULL
Thi	NULL
Tha	NULL
Thi	NULL
Th	NULL
Ag	NULL
(	NULL
hours	NULL
)	NULL
8	NULL
241	NULL
8	NULL
z	NULL
24	NULL
(	NULL
80	NULL
24	NULL
(	NULL
80	NULL
24	NULL
2G	NULL
oii	NULL
fifo	NULL
fi	NULL
58	NULL
o	NULL
,	NULL
.	NULL

0	NULL
$	NULL
00	NULL
<	NULL
<	NULL
<	NULL
o	NULL
<	NULL
<	NULL
<	NULL
<	NULL
<	NULL
?	NULL

5	NULL
8	NULL
*	NULL
>	NULL
8	NULL
antal	NULL
«	NULL
-	NULL
R	NULL
i-	NULL
Ai	NULL
-b	NULL
ic-i1	NULL
-~=~iifile	NULL
c	NULL
ne	NULL
-	NULL
>	NULL
wag	NULL
==	NULL
g	NULL
isi	NULL
t*	NULL
#	NULL
#	NULL
e	NULL
11	NULL
u	NULL
pa	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Murine	NULL
CD4*	NULL
Th2	NULL
cells	NULL
,	NULL
but	NULL
”	NULL
II	NULL
:	NULL
4:4	NULL
n	NULL
w	NULL
not	NULL
Th1	NULL
cells	NULL
,	NULL
express	NULL
GATA-3	NULL
DNA	NULL
I	NULL
binding	NULL
activity	NULL
.	NULL

Thl	NULL
and	NULL
Th2	NULL
cells	NULL
genic	NULL
mice	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experi-	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
101112	NULL
1	NULL
BProbe	NULL
Ag	NULL
(	NULL
hours	NULL
)	NULL
Competitor	NULL
Ab	NULL
,	NULL
and	NULL
complex	NULL
II	NULL
,	NULL
only	NULL
formed	NULL
with	NULL
Th2	NULL
nuclear	NULL
proteins	NULL
,	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
anti-GATA-3	NULL
Ab	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
11	NULL
)	NULL
.	NULL

Essentially	NULL
identical	NULL
data	NULL
were	NULL
obtained	NULL
in	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Ag-stimulated	NULL
D10	NULL
and	NULL
C19	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
explored	NULL
GATA-3	NULL
binding	NULL
activity	NULL
in	NULL
another	NULL
Th1l-type	NULL
clone	NULL
,	NULL
A.E7	NULL
(	NULL
35	NULL
)	NULL
.	NULL

No	NULL
IL-5	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
Northern	NULL
blot	NULL
analyses	NULL
of	NULL
RNA	NULL
prepared	NULL
from	NULL
A.E7	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
Ag	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Ag-induced	NULL
A.E7	NULL
cells	NULL
had	NULL
no	NULL
detectable	NULL
GATA-3	NULL
binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
the	NULL
exact	NULL
composition	NULL
of	NULL
the	NULL
different	NULL
complexes	NULL
that	NULL
are	NULL
formed	NULL
with	NULL
Th2	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
IL-5	NULL
GATA	NULL
site	NULL
.	NULL

Complex	NULL
II	NULL
could	NULL
represent	NULL
a	NULL
higher	NULL
order	NULL
form	NULL
(	NULL
dimer	NULL
or	NULL
tetramer	NULL
)	NULL
of	NULL
complex	NULL
I	NULL
that	NULL
may	NULL
contain	NULL
a	NULL
monomer	NULL
or	NULL
dimer	NULL
of	NULL
GATA-3	NULL
.	NULL

The	NULL
oligonucleotide	NULL
competition	NULL
experiments	NULL
suggest	NULL
that	NULL
complex	NULL
I	NULL
binds	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
with	NULL
a	NULL
lower	NULL
affinity	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
mental	NULL
Procedures	NULL
.	NULL
``	NULL

Cultures	NULL
were	NULL
maintained	NULL
for	NULL
3	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
further	NULL
stimulated	NULL
at	NULL
the	NULL
end	NULL
of	NULL
this	NULL
period	NULL
with	NULL
fresh	NULL
mitomycin	NULL
C-treated	NULL
and	NULL
T	NULL
cell-depleted	NULL
APCs	NULL
and	NULL
Ag	NULL
for	NULL
8	NULL
or	NULL
24	NULL
h	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
used	NULL
in	NULL
EMSAs	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

muf	NULL
.	NULL

,	NULL
mutant	NULL
.	NULL

9	NULL
10	NULL
11	NULL
12	NULL
than	NULL
complex	NULL
II	NULL
.	NULL

Also	NULL
,	NULL
formation	NULL
of	NULL
complex	NULL
II	NULL
was	NULL
consistently	NULL
more	NULL
sensitive	NULL
to	NULL
the	NULL
anti-GATA-3	NULL
antibody	NULL
than	NULL
formation	NULL
of	NULL
complex	NULL
I	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
epitope	NULL
recognized	NULL
by	NULL
the	NULL
anti-GATA-3	NULL
monoclonal	NULL
antibody	NULL
in	NULL
the	NULL
GATA-3	NULL
protein	NULL
is	NULL
more	NULL
accessible	NULL
in	NULL
complex	NULL
II	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
activated	NULL
Th1	NULL
cells	NULL
lack	NULL
GATA-3	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
the	NULL
reactivity	NULL
of	NULL
complex	NULL
III	NULL
to	NULL
the	NULL
anti-GATA-4	NULL
antiserum	NULL
is	NULL
unclear	NULL
at	NULL
the	NULL
present	NULL
time	NULL
since	NULL
the	NULL
expression	NULL
of	NULL
GATA-4	NULL
has	NULL
only	NULL
been	NULL
described	NULL
in	NULL
the	NULL
heart	NULL
,	NULL
intestines	NULL
,	NULL
and	NULL
gonads	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
AP-1	NULL
binding	NULL
activity	NULL
with	NULL
the	NULL
extracts	NULL
of	NULL
both	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
a	NULL
major	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
right	NULL
panel	NULL
,	NULL
shown	NULL
by	NULL
an	NULL
arrow	NULL
)	NULL
and	NULL
a	NULL
minor	NULL
complex	NULL
were	NULL
obtained	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Thl	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
for	NULL
8	NULL
h	NULL
contained	NULL
less	NULL
AP-1	NULL
binding	NULL
activity	NULL
than	NULL
extracts	NULL
from	NULL
similarly	NULL
treated	NULL
Th2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
right	NULL
panel	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GATA-3	NULL
and	NULL
Th2-specific	NULL
Transcription	NULL
and	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
AP-1	NULL
binding	NULL
activities	NULL
of	NULL
the	NULL
24-h	NULL
extracts	NULL
from	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
were	NULL
equivalent	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
.	NULL

The	NULL
supershift/inhibition	NULL
studies	NULL
again	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
JunB	NULL
and	NULL
JunD	NULL
in	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
both	NULL
Th1l	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
and	NULL
Th2	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
extracts	NULL
.	NULL

The	NULL
anti-c-Jun	NULL
Ab	NULL
also	NULL
partially	NULL
inhibited	NULL
formation	NULL
of	NULL
the	NULL
Thl-specific	NULL
complex	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
since	NULL
there	NULL
was	NULL
residual	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
complexes	NULL
generated	NULL
with	NULL
both	NULL
Th1l	NULL
and	NULL
Th2	NULL
extracts	NULL
that	NULL
was	NULL
not	NULL
abolished	NULL
by	NULL
any	NULL
of	NULL
these	NULL
antisera	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
related	NULL
proteins	NULL
are	NULL
also	NULL
present	NULL
in	NULL
the	NULL
complexes	NULL
.	NULL

The	NULL
residual	NULL
binding	NULL
appears	NULL
not	NULL
be	NULL
due	NULL
to	NULL
any	NULL
binding	NULL
to	NULL
the	NULL
Elf-l-like	NULL
site	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
since	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
EIf-1	NULL
site	NULL
was	NULL
able	NULL
to	NULL
efficiently	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
CLEO	NULL
element	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
either	NULL
clones	NULL
or	NULL
cultured	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
lower	NULL
intensity	NULL
of	NULL
the	NULL
8-h	NULL
Th1	NULL
complex	NULL
was	NULL
not	NULL
related	NULL
to	NULL
technique	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
extracts	NULL
for	NULL
binding	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
CREB	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
the	NULL
CREB	NULL
binding	NULL
activity	NULL
was	NULL
equivalent	NULL
in	NULL
the	NULL
two	NULL
nuclear	NULL
extracts	NULL
,	NULL
ruling	NULL
out	NULL
a	NULL
general	NULL
deficiency	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
Th1	NULL
cell	NULL
extracts	NULL
.	NULL

Immunoprecipi-tation	NULL
experiments	NULL
performed	NULL
with	NULL
cell	NULL
extracts	NULL
prepared	NULL
from	NULL
metabolically	NULL
labeled	NULL
cells	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
GATA-3	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
Thl	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
GATA-3	NULL
protein	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
Th2	NULL
cells	NULL
contain	NULL
GATA-3	NULL
protein	NULL
in	NULL
a	NULL
constitutive	NULL
fashion	NULL
,	NULL
which	NULL
increases	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
by	NULL
Ag	NULL
or	NULL
cAMP	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Th1	NULL
cells	NULL
express	NULL
very	NULL
little/no	NULL
GATA-3	NULL
at	NULL
the	NULL
basal	NULL
level	NULL
,	NULL
which	NULL
reproducibly	NULL
decreases	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
IL-5	NULL
Promoter	NULL
by	NULL
Ectopic	NULL
Expression	NULL
of	NULL
GATA-3-We	NULL
reasoned	NULL
that	NULL
if	NULL
GATA-3	NULL
controls	NULL
tissue-specific	NULL
expression	NULL
of	NULL
IL-5	NULL
,	NULL
then	NULL
ectopic	NULL
expression	NULL
of	NULL
GATA-3	NULL
in	NULL
non-GATA-3-expressing	NULL
cells	NULL
would	NULL
allow	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

Upon	NULL
stimulation	NULL
,	NULL
neither	NULL
Th1	NULL
clones	NULL
nor	NULL
the	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
line	NULL
HeLa	NULL
expresses	NULL
IL-5	NULL
or	NULL
GATA-3	NULL
protein	NULL
,	NULL
but	NULL
do	NULL
express	NULL
AP-1	NULL
proteins	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
expression	NULL
of	NULL
GATA-3	NULL
RNA	NULL
would	NULL
make	NULL
these	NULL
cells	NULL
permissive	NULL
for	NULL
IL-5	NULL
promoter	NULL
activation	NULL
,	NULL
Th1	NULL
cells	NULL
(	NULL
A.E7	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
or	NULL
Helia	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
1.7-kb	NULL
IL-5	NULL
promoter-reporter	NULL
construct	NULL
together	NULL
with	NULL
a	NULL
vector	NULL
for	NULL
either	NULL
sense	NULL
or	NULL
antisense	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
GATA-3	NULL
RNA	NULL
expression	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
difficult	NULL
to	NULL
sustain	NULL
high	NULL
levels	NULL
of	NULL
GATA-3	NULL
RNA	NULL
expression	NULL
in	NULL
non-Th2	NULL
cells	NULL
(	NULL
especially	NULL
in	NULL
Th1	NULL
cells	NULL
)	NULL
by	NULL
transient	NULL
transfection	NULL
methods	NULL
,	NULL
in	NULL
both	NULL
A.E7	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
expression	NULL
of	NULL
GATA-3	NULL
sense	NULL
RNA	NULL
,	NULL
but	NULL
not	NULL
antisense	NULL
RNA	NULL
,	NULL
resulted	NULL
in	NULL
4-6-fold	NULL
activation	NULL
of	NULL
the	NULL
1.7-kb	NULL
IL-5	NULL
promoter	NULL
upon	NULL
stimulation	NULL
with	NULL
Bt	NULL
,	NULL
cAMP	NULL
and	NULL
PMA	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
promoter	NULL
without	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
suggests	NULL
the	NULL
need	NULL
for	NULL
binding	NULL
of	NULL
inducible	NULL
proteins	NULL
to	NULL
other	NULL
DNA	NULL
sites	NULL
,	NULL
most	NULL
likely	NULL
the	NULL
AP-1	NULL
site	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
,	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
alone	NULL
without	NULL
GATA-3	NULL
expression	NULL
did	NULL
not	NULL
activate	NULL
the	NULL
IL-5	NULL
promoter	NULL
.	NULL

A	NULL
minimal	NULL
promoter	NULL
containing	NULL
IL-5	NULL
DNA	NULL
sequences	NULL
between	NULL
-76	NULL
and	NULL
+24	NULL
,	NULL
which	NULL
include	NULL
the	NULL
GATA	NULL
site	NULL
between	NULL
-70	NULL
and	NULL
-60	NULL
and	NULL
the	NULL
CLEO	NULL
element	NULL
,	NULL
but	NULL
no	NULL
other	NULL
identifiable	NULL
transcription	NULL
factor-binding	NULL
sites	NULL
,	NULL
was	NULL
also	NULL
similarly	NULL
activated	NULL
by	NULL
coexpres-sion	NULL
of	NULL
the	NULL
sense	NULL
(	NULL
but	NULL
not	NULL
the	NULL
antisense	NULL
)	NULL
GATA-3	NULL
expression	NULL
vector	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
overexpression	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
potent	NULL
trans-activator	NULL
,	NULL
failed	NULL
to	NULL
up-regulate	NULL
IL-5	NULL
promoter	NULL
activity	NULL
in	NULL
Helia	NULL
cells	NULL
,	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
GATA-3	NULL
in	NULL
this	NULL
experimental	NULL
setting	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
Th1	NULL
cells	NULL
and	NULL
Hela	NULL
cells	NULL
express	NULL
several	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
DNA-binding	NULL
sites	NULL
for	NULL
a	NULL
few	NULL
of	NULL
which	NULL
can	NULL
be	NULL
identified	NULL
in	NULL
the	NULL
1.7-kb	NULL
IL-5	NULL
promoter	NULL
,	NULL
these	NULL
cells	NULL
can	NULL
only	NULL
activate	NULL
the	NULL
promoter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
21601	NULL
A	NULL
a	NULL
A.E7	NULL
Be	NULL
HeLa	NULL
s5	NULL
4	NULL
Aun	NULL
F	NULL
]	NULL
un	NULL
induced	NULL
5	NULL
Winduced	NULL
5	NULL
g	NULL
c	NULL
2	NULL
2	NULL
4	NULL
,	NULL
G	NULL
3	NULL
2	NULL
g	NULL
B	NULL
1.5	NULL
3	NULL
3°	NULL
o	NULL
|	NULL
2	NULL
2	NULL
,	NULL
0.5	NULL
°	NULL
s	NULL
as	NULL
°	NULL
s	NULL
as	NULL
-	NULL
GAiTas	NULL
-	NULL
GATAs	NULL
péS	NULL
wt	NULL
IL-5	NULL
wt	NULL
IL-5	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
in	NULL
A.E7	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
GATA-3	NULL
.	NULL

A	NULL
,	NULL
A.E7	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
DNA	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
cytomegalovirus-B-galactosidase	NULL
plasmid	NULL
,	NULL
and	NULL
carrier	NULL
plasmid	NULL
with	NULL
or	NULL
without	NULL
5	NULL
ug	NULL
of	NULL
murine	NULL
GATA-3	NULL
sense	NULL
or	NULL
antisense	NULL
expression	NULL
plasmid	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
left	NULL
uninduced	NULL
or	NULL
were	NULL
induced	NULL
with	NULL
Bt	NULL
,	NULL
cAMP	NULL
+	NULL
PMA	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
-galactosidase	NULL
activity	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
results	NULL
represent	NULL
an	NULL
average	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
monolayer	NULL
cultures	NULL
of	NULL
Hela	NULL
cells	NULL
in	NULL
60-mm	NULL
plates	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
procedure	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
DNA	NULL
(	NULL
2	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
murine	NULL
GATA-3	NULL
sense	NULL
or	NULL
antisense	NULL
RNA	NULL
expression	NULL
or	NULL
p65	NULL
RNA	NULL
expression	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
cytomegalovirus-B-galactosidase	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
carrier	NULL
plasmid	NULL
)	NULL
.	NULL

16	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
in	NULL
serum-free	NULL
medium	NULL
or	NULL
stimulated	NULL
with	NULL
Bt	NULL
,	NULL
cAMP	NULL
+	NULL
PMA	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
6	NULL
h	NULL
after	NULL
stimulation	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
with	NULL
<	NULL
3	NULL
%	NULL
variation	NULL
between	NULL
experiments	NULL
.	NULL

S	NULL
,	NULL
sense	NULL
;	NULL
AS	NULL
,	NULL
antisense	NULL
;	NULL
wt	NULL
,	NULL
wild-type	NULL
.	NULL

GATA-3	NULL
.	NULL

This	NULL
strongly	NULL
suggests	NULL
that	NULL
GATA-3	NULL
serves	NULL
the	NULL
role	NULL
of	NULL
a	NULL
tissue-specific	NULL
regulator	NULL
of	NULL
IL-5	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
studies	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
involvement	NULL
of	NULL
additional	NULL
control	NULL
elements	NULL
that	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
overall	NULL
enhancement	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

Kinetics	NULL
of	NULL
GATA-3	NULL
RNA	NULL
Expression	NULL
during	NULL
Development	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
Cells	NULL
from	NULL
Naive	NULL
Spleen	NULL
Thp	NULL
Cells-To	NULL
determine	NULL
whether	NULL
the	NULL
difference	NULL
in	NULL
GATA-3	NULL
activity	NULL
between	NULL
Thl	NULL
and	NULL
Th2	NULL
cells	NULL
reflected	NULL
a	NULL
preferential	NULL
up-regulation	NULL
of	NULL
GATA-3	NULL
gene	NULL
expression	NULL
in	NULL
Th2	NULL
cells	NULL
in	NULL
the	NULL
course	NULL
of	NULL
primary	NULL
stimulation	NULL
,	NULL
naive	NULL
spleen	NULL
Thp	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
differentiate	NULL
along	NULL
a	NULL
Th1	NULL
or	NULL
Th2	NULL
pathway	NULL
by	NULL
treatment	NULL
with	NULL
Ag	NULL
and	NULL
the	NULL
appropriate	NULL
cytokines	NULL
and	NULL
anti-cytokine	NULL
antibodies	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
GATA-3	NULL
mRNA	NULL
expression	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
differentiating	NULL
cells	NULL
harvested	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
stimulation	NULL
.	NULL

Identification	NULL
of	NULL
differentiated	NULL
cells	NULL
as	NULL
predominantly	NULL
Th1	NULL
or	NULL
Th2	NULL
populations	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
ELISA	NULL
for	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IFN-y	NULL
protein	NULL
in	NULL
culture	NULL
supernatants	NULL
after	NULL
secondary	NULL
stimulation	NULL
with	NULL
Ag	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
naive	NULL
Thp	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
GATA-3	NULL
mRNA	NULL
.	NULL

In	NULL
cells	NULL
differentiated	NULL
along	NULL
a	NULL
Th2	NULL
pathway	NULL
,	NULL
there	NULL
was	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
GATA-3	NULL
mRNA	NULL
at	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
which	NULL
continued	NULL
to	NULL
increase	NULL
until	NULL
48	NULL
h	NULL
and	NULL
reached	NULL
a	NULL
plateau	NULL
thereafter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
such	NULL
induction	NULL
was	NULL
seen	NULL
in	NULL
Th1	NULL
cells	NULL
,	NULL
and	NULL
there	NULL
was	NULL
actually	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
level	NULL
of	NULL
GATA-3	NULL
message	NULL
at	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
which	NULL
reached	NULL
a	NULL
minimum	NULL
at	NULL
48	NULL
h	NULL
post-stimula-tion	NULL
,	NULL
by	NULL
which	NULL
time	NULL
a	NULL
commitment	NULL
of	NULL
the	NULL
developing	NULL
cells	NULL
along	NULL
the	NULL
Th1/Th2	NULL
lineage	NULL
has	NULL
already	NULL
occurred	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
loading	NULL
of	NULL
RNA	NULL
was	NULL
equivalent	NULL
for	NULL
the	NULL
two	NULL
sets	NULL
of	NULL
cells	NULL
as	NULL
evident	NULL
from	NULL
hybridization	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
with	NULL
glyceraldehyde-3-phos-phate	NULL
dehydrogenase	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
restimulated	NULL
after	NULL
day	NULL
5	NULL
with	NULL
fresh	NULL
T	NULL
cell-depleted	NULL
and	NULL
mitomycin	NULL
C-treated	NULL
APCs	NULL
and	NULL
Ag	NULL
for	NULL
48	NULL
h	NULL
,	NULL
and	NULL
cytokine	NULL
levels	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
were	NULL
evaluated	NULL
by	NULL
ELISA	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
experiments	NULL
show	NULL
that	NULL
differentiation	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
21602	NULL
A	NULL
8	NULL
Th2	NULL
Thi	NULL
-	NULL
aoe	NULL
S	NULL
&	NULL
0	NULL
Coos	NULL
co	NULL
a	NULL
costo	NULL
®	NULL
a	NULL
0	NULL
ON	NULL
os	NULL
U	NULL
o	NULL
-	NULL
Ooo	NULL
%	NULL
o	NULL
u	NULL
w	NULL
UW	NULL
.	NULL

mGATA-3	NULL
B	NULL
12000	NULL
35000	NULL
€000	NULL
=10000	NULL
-	NULL
80000	NULL
+	NULL
<	NULL
5000	NULL
E	NULL
E	NULL
25000	NULL
}	NULL
>	NULL
-	NULL
8000	NULL
=	NULL
4000	NULL
&	NULL
2	NULL
20000	NULL
4	NULL
&	NULL
Q	NULL
.	NULL

6000+	NULL
a	NULL
.	NULL

-	NULL
3000	NULL
m*	NULL
*	NULL
``	NULL
15000	NULL
-	NULL
>	NULL
.	NULL

<	NULL
4000	NULL
P	NULL
10000	NULL
-	NULL
3	NULL
2000+	NULL
=	NULL
!	NULL

2000+	NULL
=	NULL
sooo	NULL
+	NULL
4	NULL
1000+	NULL
o	NULL
o	NULL
t	NULL
7	NULL
*	NULL
a	NULL
vo	NULL
w	NULL
p	NULL
£	NULL
.C	NULL
£	NULL
C	NULL
£	NULL
fi-	NULL
be	NULL
o-	NULL
£	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Up-regulation	NULL
of	NULL
GATA-3	NULL
gene	NULL
expression	NULL
in	NULL
developing	NULL
Th2	NULL
cells	NULL
and	NULL
down-regulation	NULL
in	NULL
developing	NULL
Thl1	NULL
cells	NULL
.	NULL

Naive	NULL
CD4*	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
the	NULL
spleens	NULL
of	NULL
DO11.10	NULL
mice	NULL
were	NULL
allowed	NULL
to	NULL
differentiate	NULL
along	NULL
the	NULL
Th1	NULL
or	NULL
Th2	NULL
pathway	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Exper-imental	NULL
Procedures	NULL
.	NULL
``	NULL

A	NULL
,	NULL
expression	NULL
of	NULL
GATA-3	NULL
mRNA	NULL
in	NULL
developing	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blotting	NULL
techniques	NULL
.	NULL

B	NULL
,	NULL
cytokine	NULL
production	NULL
by	NULL
Th1	NULL
and	NULL
Th2	NULL
cell	NULL
populations	NULL
.	NULL

After	NULL
5	NULL
days	NULL
in	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
restimulated	NULL
with	NULL
fresh	NULL
T	NULL
cell-depleted	NULL
and	NULL
mitomycin	NULL
C-treated	NULL
APCs	NULL
and	NULL
Ag	NULL
for	NULL
48	NULL
h.	NULL
Culture	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
cytokine	NULL
production	NULL
by	NULL
ELISA	NULL
.	NULL

mGATA-3	NULL
,	NULL
murine	NULL
GATA-3	NULL
.	NULL

along	NULL
the	NULL
ThZ2	NULL
pathway	NULL
results	NULL
in	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
GATA-3	NULL
gene	NULL
expression	NULL
,	NULL
whereas	NULL
that	NULL
along	NULL
the	NULL
Th1l	NULL
pathway	NULL
leads	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
GATA-3	NULL
gene	NULL
expression	NULL
.	NULL

DISCUSSION	NULL
This	NULL
study	NULL
establishes	NULL
a	NULL
new	NULL
role	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
as	NULL
a	NULL
determinative	NULL
factor	NULL
in	NULL
Th2-specific	NULL
IL-5	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
GATA-3	NULL
double	NULL
site	NULL
is	NULL
identical	NULL
in	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
IL-5	NULL
genes	NULL
.	NULL

GATA-3	NULL
belongs	NULL
to	NULL
the	NULL
GATA	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
WGATAR	NULL
(	NULL
W	NULL
=	NULL
A/T	NULL
;	NULL
R	NULL
=	NULL
A/G	NULL
)	NULL
DNA	NULL
sequence	NULL
through	NULL
a	NULL
highly	NULL
conserved	NULL
C	NULL
,	NULL
zinc	NULL
finger	NULL
domain	NULL
.	NULL

Six	NULL
members	NULL
(	NULL
GATA-1	NULL
to	NULL
GATA-6	NULL
)	NULL
of	NULL
this	NULL
family	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
avians	NULL
,	NULL
with	NULL
homologues	NULL
in	NULL
mammals	NULL
and	NULL
amphibians	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
their	NULL
expression	NULL
profile	NULL
,	NULL
the	NULL
GATA	NULL
proteins	NULL
may	NULL
be	NULL
classified	NULL
functionally	NULL
as	NULL
hemopoietic	NULL
(	NULL
GATA-1	NULL
to	NULL
GATA-3	NULL
)	NULL
or	NULL
non-hemopoi-etic	NULL
(	NULL
GATA-4	NULL
to	NULL
GATA-6	NULL
)	NULL
,	NULL
and	NULL
this	NULL
classification	NULL
is	NULL
also	NULL
valid	NULL
from	NULL
structural	NULL
considerations	NULL
(	NULL
29	NULL
)	NULL
.	NULL

GATA-3	NULL
is	NULL
expressed	NULL
primarily	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
in	NULL
the	NULL
embryonic	NULL
brain	NULL
.	NULL

Functionally	NULL
important	NULL
GATA-3-binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
and	NULL
the	NULL
CD8	NULL
gene	NULL
(	NULL
87-41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
most	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
large	NULL
promoter	NULL
fragment	NULL
fails	NULL
to	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
respective	NULL
promoters	NULL
,	NULL
suggesting	NULL
redundancy	NULL
in	NULL
their	NULL
enhancers	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Knock	NULL
out	NULL
of	NULL
the	NULL
GATA-3	NULL
gene	NULL
in	NULL
mice	NULL
results	NULL
in	NULL
embryonic	NULL
death	NULL
on	NULL
day	NULL
12	NULL
,	NULL
with	NULL
a	NULL
failure	NULL
of	NULL
fetal	NULL
hemato-poiesis	NULL
and	NULL
defects	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
GATA-3	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
an	NULL
essential	NULL
component	NULL
in	NULL
the	NULL
earliest	NULL
steps	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
using	NULL
antisense	NULL
oligonucleotides	NULL
for	NULL
GATA-3	NULL
in	NULL
fetal	NULL
thymus	NULL
organ	NULL
cultures	NULL
(	NULL
44	NULL
)	NULL
and	NULL
using	NULL
embryonic	NULL
stem	NULL
cells	NULL
containing	NULL
homozy-gous	NULL
mutations	NULL
in	NULL
the	NULL
GATA-3	NULL
gene	NULL
and	NULL
the	NULL
RAG-2	NULL
gene	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
studies	NULL
indicate	NULL
that	NULL
GATA-3	NULL
is	NULL
not	NULL
a	NULL
functionally	NULL
redundant	NULL
GATA	NULL
family	NULL
protein	NULL
.	NULL

Activation	NULL
of	NULL
IL-5	NULL
gene	NULL
expression	NULL
by	NULL
both	NULL
Ag	NULL
and	NULL
a	NULL
combination	NULL
of	NULL
Bt	NULL
,	NULL
cAMP	NULL
and	NULL
PMA	NULL
requires	NULL
the	NULL
GATA	NULL
site	NULL
and	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
but	NULL
not	NULL
the	NULL
NF-AT	NULL
site	NULL
,	NULL
in	NULL
the	NULL
IL-5	NULL
promoter	NULL
,	NULL
and	NULL
both	NULL
stimuli	NULL
trigger	NULL
similar	NULL
binding	NULL
activities	NULL
at	NULL
the	NULL
corresponding	NULL
sites	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
TCR-CD3	NULL
GATA-3	NULL
and	NULL
Th2-specific	NULL
Transcription	NULL
complex	NULL
might	NULL
involve	NULL
stimulation	NULL
of	NULL
cAMP-dependent	NULL
signaling	NULL
pathways	NULL
in	NULL
the	NULL
cell	NULL
.	NULL

Indeed	NULL
,	NULL
engagement	NULL
of	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
by	NULL
foreign	NULL
Ag	NULL
or	NULL
by	NULL
anti-CD3	NULL
monoclonal	NULL
antibodies	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
elevation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
levels	NULL
in	NULL
T	NULL
cells	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
onset	NULL
of	NULL
DNA	NULL
synthesis	NULL
in	NULL
the	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Whereas	NULL
several	NULL
studies	NULL
have	NULL
triggered	NULL
a	NULL
heightened	NULL
appreciation	NULL
for	NULL
the	NULL
role	NULL
of	NULL
cAMP	NULL
as	NULL
an	NULL
immunomodulator	NULL
(	NULL
47	NULL
)	NULL
,	NULL
there	NULL
is	NULL
a	NULL
need	NULL
to	NULL
identify	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
cAMP	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
at	NULL
specific	NULL
stages	NULL
of	NULL
activation	NULL
or	NULL
of	NULL
differentiation	NULL
of	NULL
T	NULL
cells	NULL
following	NULL
stimulation	NULL
via	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
.	NULL

Our	NULL
studies	NULL
suggest	NULL
that	NULL
specific	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
GATA-3	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
differential	NULL
effects	NULL
of	NULL
cAMP	NULL
on	NULL
immune	NULL
responses	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
and/or	NULL
differentiation	NULL
.	NULL

There	NULL
are	NULL
two	NULL
possible	NULL
explanations	NULL
for	NULL
why	NULL
the	NULL
IL-5	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
uninduced	NULL
Th2	NULL
cells	NULL
despite	NULL
high	NULL
basal	NULL
levels	NULL
of	NULL
GATA-3	NULL
.	NULL

First	NULL
,	NULL
the	NULL
activation	NULL
by	NULL
GATA-3	NULL
requires	NULL
post-translational	NULL
modification	NULL
of	NULL
the	NULL
protein	NULL
;	NULL
indeed	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
several	NULL
potential	NULL
protein	NULL
kinase	NULL
A	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
phosphorylation	NULL
sites	NULL
in	NULL
the	NULL
GATA-3	NULL
protein	NULL
.	NULL

Second	NULL
,	NULL
IL-5	NULL
promoter	NULL
activation	NULL
also	NULL
requires	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
within	NULL
the	NULL
CLEO	NULL
element	NULL
(	NULL
also	NULL
identical	NULL
in	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
genes	NULL
)	NULL
,	NULL
which	NULL
is	NULL
only	NULL
achieved	NULL
once	NULL
the	NULL
cells	NULL
are	NULL
acti-vated	NULL
.	NULL

Among	NULL
the	NULL
AP-1	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
we	NULL
have	NULL
detected	NULL
only	NULL
JunB	NULL
and	NULL
JunD	NULL
in	NULL
the	NULL
complex	NULL
that	NULL
forms	NULL
with	NULL
the	NULL
CLEO	NULL
element	NULL
using	NULL
both	NULL
Thl	NULL
and	NULL
Th2	NULL
extracts	NULL
.	NULL

Induction	NULL
of	NULL
JunB	NULL
transcription	NULL
by	NULL
cAMP	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
our	NULL
findings	NULL
,	NULL
in	NULL
one	NULL
of	NULL
these	NULL
studies	NULL
(	NULL
45	NULL
)	NULL
,	NULL
anti-Jun	NULL
or	NULL
anti-Fos	NULL
antibodies	NULL
did	NULL
not	NULL
completely	NULL
supershift/inhibit	NULL
cAMP	NULL
-induced	NULL
complexes	NULL
formed	NULL
with	NULL
an	NULL
AP-1	NULL
site	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
Ag	NULL
and	NULL
Bt	NULL
,	NULL
cAMP	NULL
induce	NULL
the	NULL
formation	NULL
of	NULL
heterodimers	NULL
of	NULL
JunB/JunD	NULL
with	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
Jun-re-lated	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
complex	NULL
exhibits	NULL
a	NULL
lower	NULL
affinity	NULL
for	NULL
anti-JunB	NULL
and	NULL
anti-JunD	NULL
antibodies	NULL
.	NULL

Alternatively	NULL
,	NULL
cAMP	NULL
induces	NULL
the	NULL
formation	NULL
of	NULL
heteromeric	NULL
complexes	NULL
between	NULL
.	NULL

JunB/JunD	NULL
and	NULL
other	NULL
related	NULL
bZIP	NULL
proteins	NULL
.	NULL

Although	NULL
the	NULL
AP-1	NULL
proteins	NULL
recognize	NULL
the	NULL
TPA	NULL
response	NULL
element	NULL
,	NULL
which	NULL
differs	NULL
from	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
by	NULL
only	NULL
1	NULL
base	NULL
pair	NULL
,	NULL
the	NULL
distinction	NULL
between	NULL
the	NULL
TPA	NULL
response	NULL
element/cAMP	NULL
response	NULL
element	NULL
and	NULL
AP-1/CREB	NULL
is	NULL
,	NULL
however	NULL
,	NULL
not	NULL
absolute	NULL
.	NULL

TPA	NULL
response	NULL
element	NULL
and	NULL
cAMP	NULL
response	NULL
element-related	NULL
sequences	NULL
have	NULL
now	NULL
been	NULL
identified	NULL
that	NULL
are	NULL
recognized	NULL
by	NULL
both	NULL
groups	NULL
of	NULL
proteins	NULL
,	NULL
and	NULL
heterodimers	NULL
between	NULL
some	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
family	NULL
and	NULL
JunB	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
c-Jun	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
50	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
IL-5	NULL
promoter	NULL
might	NULL
therefore	NULL
be	NULL
composed	NULL
of	NULL
heteromeric	NULL
complexes	NULL
between	NULL
JunB/JunD	NULL
and	NULL
CREB/ATF	NULL
proteins	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
c-Maf	NULL
,	NULL
the	NULL
product	NULL
of	NULL
the	NULL
proto-oncogene	NULL
c-maf	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
multiple	NULL
studies	NULL
by	NULL
different	NULL
investigators	NULL
indicate	NULL
that	NULL
several	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
promoter	NULL
proximal	NULL
region	NULL
or	NULL
to	NULL
regions	NULL
outside	NULL
of	NULL
the	NULL
800-bp	NULL
IL-4	NULL
promoter	NULL
may	NULL
coordinately	NULL
regulate	NULL
overall	NULL
IL-4	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
Th2	NULL
specificity	NULL
being	NULL
conferred	NULL
by	NULL
proteins	NULL
such	NULL
as	NULL
c-Maf	NULL
and	NULL
probably	NULL
also	NULL
NF-IL-6	NULL
,	NULL
which	NULL
,	NULL
like	NULL
c-Maf	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
(	NULL
52-54	NULL
)	NULL
.	NULL

The	NULL
IL-4	NULL
promoter	NULL
also	NULL
contains	NULL
a	NULL
double	NULL
GATA	NULL
site	NULL
between	NULL
-274	NULL
and	NULL
-264	NULL
(	NULL
which	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
in	NULL
the	NULL
IL-5	NULL
promoter	NULL
located	NULL
between	NULL
-70	NULL
and	NULL
-60	NULL
)	NULL
and	NULL
a	NULL
single	NULL
GATA	NULL
motif	NULL
between	NULL
-112	NULL
and	NULL
-107	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
examine	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
large	NULL
promoter	NULL
fragment	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
GATA	NULL
sites	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
ectopically	NULL
expressed	NULL
GATA-3	NULL
on	NULL
wild-type	NULL
promoter	NULL
activity	NULL
.	NULL

At	NULL
the	NULL
RNA	NULL
level	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
GATA-3	NULL
in	NULL
Thl	NULL
cells	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GATA-3	NULL
and	NULL
Th2-specific	NULL
Transcription	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
is	NULL
at	NULL
one-twentieth	NULL
to	NULL
one-thirtieth	NULL
the	NULL
level	NULL
detected	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

In	NULL
EMSAs	NULL
,	NULL
we	NULL
have	NULL
consistently	NULL
detected	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
GATA-3	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
resting	NULL
Thl	NULL
clones	NULL
C19	NULL
and	NULL
A.E7	NULL
.	NULL

Also	NULL
,	NULL
this	NULL
activity	NULL
reproducibly	NULL
decreases	NULL
upon	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
whether	NULL
by	NULL
Ag	NULL
or	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
BtycAMP	NULL
and	NULL
PMA	NULL
.	NULL

This	NULL
decrease	NULL
in	NULL
binding	NULL
activity	NULL
may	NULL
result	NULL
from	NULL
a	NULL
higher	NULL
rate	NULL
of	NULL
turnover	NULL
of	NULL
GATA-3	NULL
RNA	NULL
in	NULL
activated	NULL
Th1	NULL
cells	NULL
as	NULL
seen	NULL
in	NULL
developing	NULL
Th1	NULL
cells	NULL
during	NULL
a	NULL
primary	NULL
stimulation	NULL
of	NULL
naive	NULL
primary	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
effect	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
specifically	NULL
targeted	NULL
at	NULL
GATA-3	NULL
since	NULL
the	NULL
same	NULL
extracts	NULL
used	NULL
at	NULL
half	NULL
the	NULL
amounts	NULL
displayed	NULL
significant	NULL
inducible	NULL
binding	NULL
activity	NULL
at	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
GATA-3	NULL
levels	NULL
in	NULL
stimulated	NULL
Th1	NULL
cells	NULL
is	NULL
another	NULL
mechanism	NULL
that	NULL
ensures	NULL
the	NULL
specific	NULL
profile	NULL
of	NULL
cytokine	NULL
production	NULL
by	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Studies	NULL
of	NULL
asthma	NULL
in	NULL
both	NULL
human	NULL
and	NULL
animal	NULL
models	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
concept	NULL
that	NULL
airway	NULL
inflammation	NULL
,	NULL
a	NULL
characteristic	NULL
feature	NULL
of	NULL
asthma	NULL
,	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
activated	NULL
Th2	NULL
cells	NULL
.	NULL

Among	NULL
the	NULL
Th2	NULL
cytokines	NULL
,	NULL
IL-5	NULL
is	NULL
key	NULL
to	NULL
the	NULL
eosinophilia	NULL
typically	NULL
associated	NULL
with	NULL
the	NULL
disease	NULL
,	NULL
being	NULL
intimately	NULL
involved	NULL
with	NULL
eosinophil	NULL
differentiation	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
sur-vival	NULL
.	NULL

Eosinophilia	NULL
is	NULL
also	NULL
a	NULL
feature	NULL
of	NULL
a	NULL
number	NULL
of	NULL
other	NULL
pathological	NULL
conditions	NULL
such	NULL
as	NULL
idiopathic	NULL
hypereosinophilic	NULL
syn-drome	NULL
,	NULL
parasitic	NULL
infections	NULL
,	NULL
and	NULL
allergies	NULL
(	NULL
12	NULL
)	NULL
.	NULL

If	NULL
asthma	NULL
results	NULL
from	NULL
an	NULL
abnormal	NULL
skewing	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
in	NULL
the	NULL
lung	NULL
toward	NULL
the	NULL
generation	NULL
of	NULL
Th2	NULL
cells	NULL
,	NULL
then	NULL
understanding	NULL
the	NULL
reversal	NULL
of	NULL
this	NULL
process	NULL
is	NULL
critical	NULL
.	NULL

One	NULL
important	NULL
target	NULL
for	NULL
the	NULL
development	NULL
of	NULL
anti-asthma	NULL
therapeutics	NULL
is	NULL
therefore	NULL
inhibition	NULL
of	NULL
IL-5	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

GATA-3	NULL
is	NULL
an	NULL
especially	NULL
attractive	NULL
target	NULL
in	NULL
this	NULL
regard	NULL
since	NULL
its	NULL
expression	NULL
is	NULL
limited	NULL
to	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
adult	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
any	NULL
GATA-3-specific	NULL
antagonist	NULL
can	NULL
be	NULL
expected	NULL
to	NULL
have	NULL
minimum	NULL
side	NULL
effects	NULL
.	NULL

Another	NULL
important	NULL
question	NULL
that	NULL
arises	NULL
from	NULL
this	NULL
study	NULL
is	NULL
whether	NULL
forced	NULL
expression	NULL
of	NULL
GATA-3	NULL
in	NULL
Th1	NULL
cells	NULL
would	NULL
aid	NULL
in	NULL
altering	NULL
Th1/Th2	NULL
ratios	NULL
.	NULL

This	NULL
is	NULL
important	NULL
in	NULL
controlling	NULL
Thl-driven	NULL
pathologies	NULL
,	NULL
which	NULL
include	NULL
autoimmune	NULL
diseases	NULL
such	NULL
as	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
study	NULL
investigating	NULL
the	NULL
role	NULL
of	NULL
CD4	NULL
*	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
diabetes	NULL
mellitus	NULL
,	NULL
Th1	NULL
cells	NULL
promoted	NULL
disease	NULL
,	NULL
whereas	NULL
Th2	NULL
cells	NULL
did	NULL
not	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
study	NULL
identifies	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
GATA-3	NULL
gene	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
and	NULL
relates	NULL
it	NULL
to	NULL
the	NULL
production	NULL
of	NULL
a	NULL
cytokine	NULL
of	NULL
significant	NULL
biomedical	NULL
importance	NULL
.	NULL

This	NULL
raises	NULL
intriguing	NULL
questions	NULL
about	NULL
the	NULL
role	NULL
of	NULL
GATA-3	NULL
in	NULL
determining	NULL
the	NULL
balance	NULL
between	NULL
Th1	NULL
and	NULL
Th2	NULL
subsets	NULL
in	NULL
immune	NULL
responses	NULL
and	NULL
disease	NULL
states	NULL
.	NULL

Additionally	NULL
,	NULL
identification	NULL
of	NULL
GATA-3	NULL
as	NULL
a	NULL
critical	NULL
component	NULL
in	NULL
IL-5	NULL
gene	NULL
expression	NULL
raises	NULL
possibilities	NULL
for	NULL
the	NULL
therapy	NULL
of	NULL
asthma	NULL
and	NULL
allergic	NULL
diseases	NULL
and	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
via	NULL
blockade	NULL
of	NULL
GATA-3	NULL
activation	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
T.	NULL
Honjo	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
the	NULL
plasmid	NULL
pA4k-pUC18	NULL
containing	NULL
IL-5	NULL
promoter	NULL
sequences	NULL
,	NULL
J.	NULL
D.	NULL
Engel	NULL
for	NULL
the	NULL
plasmid	NULL
containing	NULL
the	NULL
murine	NULL
GATA-3	NULL
cDNA	NULL
and	NULL
GATA-3	NULL
expression	NULL
vectors	NULL
,	NULL
K.	NULL
M.	NULL
Murphy	NULL
for	NULL
the	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
mice	NULL
,	NULL
D.	NULL
Wilson	NULL
for	NULL
the	NULL
anti-GATA-4	NULL
antiserum	NULL
,	NULL
and	NULL
A.	NULL
Marinov	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
with	NULL
ELISAs	NULL
.	NULL

REFERENCES	NULL
.	NULL

Bottomly	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
9	NULL
,	NULL
268-278	NULL
.	NULL

Mossman	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Coffman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
145-173	NULL
.	NULL

Janeway	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Jr.	NULL
and	NULL
Bottomly	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
275-285	NULL
.	NULL

Abbas	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Murphy	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Sher	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nature	NULL
8838	NULL
,	NULL
787-798	NULL
.	NULL

Walker	NULL
,	NULL
C.	NULL
,	NULL
Virchow	NULL
,	NULL
J.	NULL
,	NULL
Bruijnzeel	NULL
,	NULL
P.	NULL
L.	NULL
B.	NULL
,	NULL
and	NULL
Blaser	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

1990	NULL
,	NULL
1829-1835	NULL
.	NULL

Hamid	NULL
,	NULL
Q.	NULL
,	NULL
Azzawi	NULL
,	NULL
M.	NULL
,	NULL
Ying	NULL
,	NULL
S.	NULL
,	NULL
Mogbel	NULL
,	NULL
R.	NULL
,	NULL
Wardlaw	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Corrigan	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Bradley	NULL
,	NULL
B.	NULL
,	NULL
Durham	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Collins	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
Jeffery	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Quint	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Kay	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87	NULL
,	NULL
1541-1546	NULL
7	NULL
.	NULL

Robinson	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Hamid	NULL
,	NULL
Q.	NULL
,	NULL
Ying	NULL
,	NULL
S.	NULL
,	NULL
Tsicopoulos	NULL
,	NULL
A.	NULL
,	NULL
Barkans	NULL
,	NULL
J.	NULL
,	NULL
Bentley	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Corrigan	NULL
,	NULL
C.	NULL
,	NULL
Durham	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
Kay	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

326	NULL
,	NULL
208-304	NULL
gim	NULL
to	NULL
bo	NULL
|	NULL
&	NULL
8	NULL
.	NULL

9	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

21603	NULL
Krishnaswamy	NULL
,	NULL
G.	NULL
,	NULL
Liu	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Su	NULL
,	NULL
S.	NULL
,	NULL
Kumai	NULL
,	NULL
M.	NULL
,	NULL
Xiao	NULL
,	NULL
H.	NULL
,	NULL
Marsh	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
and	NULL
Huang	NULL
,	NULL
9	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
279-286	NULL
Martin	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
Kita	NULL
,	NULL
H.	NULL
,	NULL
Leiferman	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Gleich	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Int	NULL
.	NULL

Arch	NULL
.	NULL

Allergy	NULL
Immunol	NULL
.	NULL

109	NULL
,	NULL
207-215	NULL
Frick	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Sedgwick	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Busse	NULL
,	NULL
W.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

139	NULL
,	NULL
1401-1406	NULL
Bousquet	NULL
,	NULL
J.	NULL
,	NULL
Chanez	NULL
,	NULL
P.	NULL
,	NULL
Lacoste	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Barneon	NULL
,	NULL
G.	NULL
,	NULL
Ghavanian	NULL
,	NULL
N.	NULL
,	NULL
Enander	NULL
,	NULL
I.	NULL
,	NULL
Venge	NULL
,	NULL
P.	NULL
,	NULL
Ablstedt	NULL
,	NULL
S.	NULL
,	NULL
Simony-Lafontaine	NULL
,	NULL
J.	NULL
,	NULL
Godard	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Michel	NULL
,	NULL
F.	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

828	NULL
,	NULL
1033-1039	NULL
Sanderson	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
3101-8109	NULL
Kamei	NULL
,	NULL
T.	NULL
,	NULL
Ozaki	NULL
,	NULL
T.	NULL
,	NULL
Kawaji	NULL
,	NULL
K.	NULL
,	NULL
Banno	NULL
,	NULL
K.	NULL
,	NULL
Sano	NULL
,	NULL
T.	NULL
,	NULL
Azuma	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Ogura	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
378-385	NULL
Gulbenkian	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Egan	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Fernandez	NULL
,	NULL
X.	NULL
,	NULL
Jones	NULL
,	NULL
H.	NULL
,	NULL
Kreutner	NULL
,	NULL
W.	NULL
,	NULL
Kung	NULL
,	NULL
T.	NULL
,	NULL
Payvandi	NULL
,	NULL
F.	NULL
,	NULL
Sullivan	NULL
,	NULL
L.	NULL
,	NULL
Zurcher	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Watnick	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

146	NULL
,	NULL
263-265	NULL
Nakajima	NULL
,	NULL
H.	NULL
,	NULL
Iwamoto	NULL
,	NULL
I.	NULL
,	NULL
Tomoe	NULL
,	NULL
S.	NULL
,	NULL
Matsumura	NULL
,	NULL
R.	NULL
,	NULL
Tomioka	NULL
,	NULL
H.	NULL
,	NULL
Takatsu	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

146	NULL
,	NULL
374-377	NULL
Foster	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Hogan	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Ramsay	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Matthaci	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
I.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
195-201	NULL
Kopf	NULL
,	NULL
M.	NULL
,	NULL
Brombacher	NULL
,	NULL
F.	NULL
,	NULL
Hodgkin	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Ramsay	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Milbourne	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Dai	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ovington	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Behm	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Kohler	NULL
,	NULL
G.	NULL
,	NULL
Young	NULL
,	NULL
I.	NULL
G.	NULL
,	NULL
and	NULL
Matthaei	NULL
,	NULL
K.	NULL
I	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
15-24	NULL
Plaut	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Watson	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Hanley-Hyde	NULL
,	NULL
J.	NULL
,	NULL
Nordan	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
389	NULL
,	NULL
64-67	NULL
Broide	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Paine	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Firestein	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
1414-1424	NULL
Bohjanen	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Okajima	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hodes	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
5288-5287	NULL
Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Koyano-Nakagawa	NULL
,	NULL
N.	NULL
,	NULL
Naito	NULL
,	NULL
Y.	NULL
,	NULL
Nishida	NULL
,	NULL
J.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Yokota	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
6185-6142	NULL
van	NULL
der	NULL
Pouw	NULL
Kraan	NULL
,	NULL
T.	NULL
C.	NULL
T.	NULL
M.	NULL
,	NULL
Boeije	NULL
,	NULL
L.	NULL
C.	NULL
M.	NULL
,	NULL
Smeenk	NULL
,	NULL
R.	NULL
J.	NULL
T.	NULL
,	NULL
Wijdenes	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Aarden	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
T75-779	NULL
Munoz	NULL
,	NULL
E.	NULL
,	NULL
Zubiaga	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Merrow	NULL
,	NULL
M.	NULL
,	NULL
Sauter	NULL
,	NULL
N.	NULL
P.	NULL
,	NULL
and	NULL
Huber	NULL
,	NULL
B.	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

1990	NULL
,	NULL
95-103	NULL
Snijdewint	NULL
,	NULL
F.	NULL
G.	NULL
M.	NULL
,	NULL
Kalinski	NULL
,	NULL
P.	NULL
,	NULL
Wicrenga	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Bos	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Kapsenberg	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
5821-5329	NULL
Siegel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Zhang	NULL
,	NULL
D.-H.	NULL
,	NULL
Ray	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ray	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
24548-24555	NULL
Yamagata	NULL
,	NULL
T.	NULL
,	NULL
Nishida	NULL
,	NULL
J.	NULL
,	NULL
Sakai	NULL
,	NULL
R.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Honda	NULL
,	NULL
H.	NULL
,	NULL
Hirano	NULL
,	NULL
N.	NULL
,	NULL
Mano	NULL
,	NULL
H.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3830-3839	NULL
Noma	NULL
,	NULL
T.	NULL
,	NULL
Nakakubo	NULL
,	NULL
H.	NULL
,	NULL
Sugita	NULL
,	NULL
M.	NULL
,	NULL
Kumagai	NULL
,	NULL
S.	NULL
,	NULL
Maeda	NULL
,	NULL
M.	NULL
,	NULL
Shimizu	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Honjo	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169	NULL
,	NULL
1858-1858	NULL
Arceci	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
King	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
2285-2246	NULL
Laverriere	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
MacNeill	NULL
,	NULL
C.	NULL
,	NULL
Mueller	NULL
,	NULL
C.	NULL
,	NULL
Poelmann	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Burch	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
E.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
28177-23184	NULL
Prieschl	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Goouilleux-Gruart	NULL
,	NULL
V.	NULL
,	NULL
Walker	NULL
,	NULL
C.	NULL
,	NULL
Harrer	NULL
,	NULL
N.	NULL
E.	NULL
,	NULL
and	NULL
Baumruker	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
6112-6119	NULL
Kaye	NULL
,	NULL
J.	NULL
,	NULL
Porcelli	NULL
,	NULL
S.	NULL
,	NULL
Tite	NULL
,	NULL
J.	NULL
,	NULL
Jones	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Janeway	NULL
,	NULL
J.	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

158	NULL
,	NULL
836-856	NULL
Baron	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Madri	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ruddle	NULL
,	NULL
N.	NULL
H.	NULL
,	NULL
Hashim	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Janeway	NULL
,	NULL
J.	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177	NULL
,	NULL
57-68	NULL
Ray	NULL
,	NULL
A.	NULL
,	NULL
LaForge	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Sehgal	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7086-7090	NULL
Ray	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Prefontaine	NULL
,	NULL
K.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
752-756	NULL
Beverly	NULL
,	NULL
B.	NULL
,	NULL
Kang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

4	NULL
,	NULL
661-671	NULL
Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Kamogawa	NULL
,	NULL
Y.	NULL
,	NULL
Bottomly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
1085-1094	NULL
Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
Vorhees	NULL
,	NULL
P.	NULL
,	NULL
Marin	NULL
,	NULL
N.	NULL
,	NULL
Oakley	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Tsai	NULL
,	NULL
S.-F.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1187-1192	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
George	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2778-2784	NULL
Marine	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Winoto	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7284-7288	NULL
Hambor	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Mennone	NULL
,	NULL
J.	NULL
,	NULL
Coon	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Hanke	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Kavathas	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7056-7070	NULL
Henderson	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
McDougall	NULL
,	NULL
S.	NULL
,	NULL
Leiden	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Calame	NULL
,	NULL
K.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4286-4294	NULL
Smith	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
Lee	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
Szychowski	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Winoto	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
1515-1520	NULL
Pandolfi	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
Roth	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Karis	NULL
,	NULL
A.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Dzierzak	NULL
,	NULL
E.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Lindenbaum	NULL
,	NULL
M.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Nat	NULL
.	NULL

Genet	NULL
.	NULL

11	NULL
,	NULL
40-44	NULL
Hattori	NULL
,	NULL
N.	NULL
,	NULL
Kawamoto	NULL
,	NULL
H.	NULL
,	NULL
Fujimoto	NULL
,	NULL
S.	NULL
,	NULL
Kuno	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Katsura	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
1137-1147	NULL
Ting	NULL
,	NULL
C.-N.	NULL
,	NULL
Olson	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Barton	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
384	NULL
,	NULL
474-478	NULL
Feuerstein	NULL
,	NULL
N.	NULL
,	NULL
Firestein	NULL
,	NULL
R.	NULL
,	NULL
Aiyar	NULL
,	NULL
N.	NULL
,	NULL
He	NULL
,	NULL
X.	NULL
,	NULL
Murasko	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Cristofalo	NULL
,	NULL
V.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
4582-4593	NULL
Haraguchi	NULL
,	NULL
S.	NULL
,	NULL
Good	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Day	NULL
,	NULL
N.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
16	NULL
,	NULL
595-603	NULL
Tamir	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Isakov	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
3391-8399	NULL
Amato	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Chiles	NULL
,	NULL
T.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
146-155	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Oncogene	NULL
5	NULL
,	NULL
427-481	NULL
Ho	NULL
,	NULL
L-C.	NULL
,	NULL
Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
973-983	NULL
Davydov	NULL
,	NULL
I.	NULL
V.	NULL
,	NULL
Krammer	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Li-Weber	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
5273-5279	NULL
Li-Weber	NULL
,	NULL
M.	NULL
,	NULL
Salgame	NULL
,	NULL
M.	NULL
,	NULL
Hu	NULL
,	NULL
C.	NULL
,	NULL
Davydov	NULL
,	NULL
I.	NULL
V.	NULL
,	NULL
and	NULL
Krammer	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
1194-1200	NULL
Wenner	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
765-773	NULL
Katz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
1185-1188	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Transcription	NULL
Factor	NULL
GATA-3	NULL
Is	NULL
Differentially	NULL
Expressed	NULL
in	NULL
Murine	NULL
Th1	NULL
and	NULL
Th2	NULL
Cells	NULL
and	NULL
Controls	NULL
Th2-specific	NULL
Expression	NULL
of	NULL
the	NULL
Interleukin-5	NULL
Gene	NULL
Dong-Hong	NULL
Zhang	NULL
,	NULL
Lauren	NULL
Cohn	NULL
,	NULL
Prabir	NULL
Ray	NULL
,	NULL
Kim	NULL
Bottomly	NULL
and	NULL
Anuradha	NULL
Ray	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:21597-21603.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.34.21597	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/34/21597	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
55	NULL
references	NULL
,	NULL
29	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

